0000065270 false --05-01 2021 Q3 P91D P98D P273D P280D 0 0 P15Y9M18D P7Y2M12D P16Y6M P7Y9M18D 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0000065270 2020-05-03 2021-01-30 xbrli:shares 0000065270 2021-03-01 iso4217:USD 0000065270 2020-11-01 2021-01-30 0000065270 2019-10-27 2020-02-01 0000065270 2019-05-02 2020-02-01 iso4217:USD xbrli:shares 0000065270 2019-04-28 2020-02-01 0000065270 2021-01-30 0000065270 2020-05-02 0000065270 us-gaap:CommonStockMember 2020-10-31 0000065270 us-gaap:AdditionalPaidInCapitalMember 2020-10-31 0000065270 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-10-31 0000065270 us-gaap:TreasuryStockMember 2020-10-31 0000065270 us-gaap:RetainedEarningsMember 2020-10-31 0000065270 2020-10-31 0000065270 us-gaap:CommonStockMember 2020-11-01 2021-01-30 0000065270 us-gaap:AdditionalPaidInCapitalMember 2020-11-01 2021-01-30 0000065270 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-11-01 2021-01-30 0000065270 us-gaap:RetainedEarningsMember 2020-11-01 2021-01-30 0000065270 us-gaap:CommonStockMember 2021-01-30 0000065270 us-gaap:AdditionalPaidInCapitalMember 2021-01-30 0000065270 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-30 0000065270 us-gaap:TreasuryStockMember 2021-01-30 0000065270 us-gaap:RetainedEarningsMember 2021-01-30 0000065270 us-gaap:CommonStockMember 2019-10-26 0000065270 us-gaap:AdditionalPaidInCapitalMember 2019-10-26 0000065270 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-10-26 0000065270 us-gaap:TreasuryStockMember 2019-10-26 0000065270 us-gaap:RetainedEarningsMember 2019-10-26 0000065270 2019-10-26 0000065270 us-gaap:AdditionalPaidInCapitalMember 2019-10-27 2020-02-01 0000065270 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-10-27 2020-02-01 0000065270 us-gaap:RetainedEarningsMember 2019-10-27 2020-02-01 0000065270 us-gaap:CommonStockMember 2020-02-01 0000065270 us-gaap:AdditionalPaidInCapitalMember 2020-02-01 0000065270 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-02-01 0000065270 us-gaap:TreasuryStockMember 2020-02-01 0000065270 us-gaap:RetainedEarningsMember 2020-02-01 0000065270 2020-02-01 0000065270 us-gaap:CommonStockMember 2020-05-02 0000065270 us-gaap:AdditionalPaidInCapitalMember 2020-05-02 0000065270 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-05-02 0000065270 us-gaap:TreasuryStockMember 2020-05-02 0000065270 us-gaap:RetainedEarningsMember 2020-05-02 0000065270 us-gaap:CommonStockMember 2020-05-03 2021-01-30 0000065270 us-gaap:AdditionalPaidInCapitalMember 2020-05-03 2021-01-30 0000065270 us-gaap:RetainedEarningsMember 2020-05-03 2021-01-30 0000065270 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-05-03 2021-01-30 0000065270 us-gaap:CommonStockMember 2019-04-27 0000065270 us-gaap:AdditionalPaidInCapitalMember 2019-04-27 0000065270 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-04-27 0000065270 us-gaap:TreasuryStockMember 2019-04-27 0000065270 us-gaap:RetainedEarningsMember 2019-04-27 0000065270 2019-04-27 0000065270 us-gaap:CommonStockMember 2019-04-28 2020-02-01 0000065270 us-gaap:RetainedEarningsMember 2019-04-28 2020-02-01 0000065270 us-gaap:AdditionalPaidInCapitalMember 2019-04-28 2020-02-01 0000065270 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-04-28 2020-02-01 0000065270 mei:TwoThousandFourteenStockPlanMember 2020-05-03 2021-01-30 0000065270 mei:TwoThousandTenAndTwoThousandSevenStockPlanMember 2020-05-03 2021-01-30 0000065270 mei:Covid19Member 2020-11-01 2021-01-30 0000065270 mei:Covid19Member 2020-05-03 2021-01-30 0000065270 us-gaap:AccountingStandardsUpdate201602Member 2021-01-30 0000065270 us-gaap:AccountingStandardsUpdate201602Member 2020-05-02 0000065270 srt:NorthAmericaMember mei:AutomotiveMember 2020-11-01 2021-01-30 0000065270 srt:NorthAmericaMember mei:IndustrialMember 2020-11-01 2021-01-30 0000065270 srt:NorthAmericaMember mei:InterfaceMember 2020-11-01 2021-01-30 0000065270 srt:NorthAmericaMember mei:MedicalMember 2020-11-01 2021-01-30 0000065270 srt:NorthAmericaMember 2020-11-01 2021-01-30 0000065270 srt:EuropeMember mei:AutomotiveMember 2020-11-01 2021-01-30 0000065270 srt:EuropeMember mei:IndustrialMember 2020-11-01 2021-01-30 0000065270 srt:EuropeMember 2020-11-01 2021-01-30 0000065270 srt:AsiaMember mei:AutomotiveMember 2020-11-01 2021-01-30 0000065270 srt:AsiaMember mei:IndustrialMember 2020-11-01 2021-01-30 0000065270 srt:AsiaMember mei:InterfaceMember 2020-11-01 2021-01-30 0000065270 srt:AsiaMember 2020-11-01 2021-01-30 0000065270 mei:AutomotiveMember 2020-11-01 2021-01-30 0000065270 mei:IndustrialMember 2020-11-01 2021-01-30 0000065270 mei:InterfaceMember 2020-11-01 2021-01-30 0000065270 mei:MedicalMember 2020-11-01 2021-01-30 0000065270 us-gaap:TransferredAtPointInTimeMember mei:AutomotiveMember 2020-11-01 2021-01-30 0000065270 us-gaap:TransferredAtPointInTimeMember mei:IndustrialMember 2020-11-01 2021-01-30 0000065270 us-gaap:TransferredAtPointInTimeMember mei:InterfaceMember 2020-11-01 2021-01-30 0000065270 us-gaap:TransferredAtPointInTimeMember mei:MedicalMember 2020-11-01 2021-01-30 0000065270 us-gaap:TransferredAtPointInTimeMember 2020-11-01 2021-01-30 0000065270 us-gaap:TransferredOverTimeMember mei:AutomotiveMember 2020-11-01 2021-01-30 0000065270 us-gaap:TransferredOverTimeMember 2020-11-01 2021-01-30 0000065270 srt:NorthAmericaMember mei:AutomotiveMember 2019-10-27 2020-02-01 0000065270 srt:NorthAmericaMember mei:IndustrialMember 2019-10-27 2020-02-01 0000065270 srt:NorthAmericaMember mei:InterfaceMember 2019-10-27 2020-02-01 0000065270 srt:NorthAmericaMember mei:MedicalMember 2019-10-27 2020-02-01 0000065270 srt:NorthAmericaMember 2019-10-27 2020-02-01 0000065270 srt:EuropeMember mei:AutomotiveMember 2019-10-27 2020-02-01 0000065270 srt:EuropeMember mei:IndustrialMember 2019-10-27 2020-02-01 0000065270 srt:EuropeMember mei:InterfaceMember 2019-10-27 2020-02-01 0000065270 srt:EuropeMember 2019-10-27 2020-02-01 0000065270 srt:AsiaMember mei:AutomotiveMember 2019-10-27 2020-02-01 0000065270 srt:AsiaMember mei:IndustrialMember 2019-10-27 2020-02-01 0000065270 srt:AsiaMember mei:InterfaceMember 2019-10-27 2020-02-01 0000065270 srt:AsiaMember 2019-10-27 2020-02-01 0000065270 mei:AutomotiveMember 2019-10-27 2020-02-01 0000065270 mei:IndustrialMember 2019-10-27 2020-02-01 0000065270 mei:InterfaceMember 2019-10-27 2020-02-01 0000065270 mei:MedicalMember 2019-10-27 2020-02-01 0000065270 us-gaap:TransferredAtPointInTimeMember mei:AutomotiveMember 2019-10-27 2020-02-01 0000065270 us-gaap:TransferredAtPointInTimeMember mei:IndustrialMember 2019-10-27 2020-02-01 0000065270 us-gaap:TransferredAtPointInTimeMember mei:InterfaceMember 2019-10-27 2020-02-01 0000065270 us-gaap:TransferredAtPointInTimeMember mei:MedicalMember 2019-10-27 2020-02-01 0000065270 us-gaap:TransferredAtPointInTimeMember 2019-10-27 2020-02-01 0000065270 us-gaap:TransferredOverTimeMember mei:AutomotiveMember 2019-10-27 2020-02-01 0000065270 us-gaap:TransferredOverTimeMember 2019-10-27 2020-02-01 0000065270 srt:NorthAmericaMember mei:AutomotiveMember 2020-05-03 2021-01-30 0000065270 srt:NorthAmericaMember mei:IndustrialMember 2020-05-03 2021-01-30 0000065270 srt:NorthAmericaMember mei:InterfaceMember 2020-05-03 2021-01-30 0000065270 srt:NorthAmericaMember mei:MedicalMember 2020-05-03 2021-01-30 0000065270 srt:NorthAmericaMember 2020-05-03 2021-01-30 0000065270 srt:EuropeMember mei:AutomotiveMember 2020-05-03 2021-01-30 0000065270 srt:EuropeMember mei:IndustrialMember 2020-05-03 2021-01-30 0000065270 srt:EuropeMember 2020-05-03 2021-01-30 0000065270 srt:AsiaMember mei:AutomotiveMember 2020-05-03 2021-01-30 0000065270 srt:AsiaMember mei:IndustrialMember 2020-05-03 2021-01-30 0000065270 srt:AsiaMember mei:InterfaceMember 2020-05-03 2021-01-30 0000065270 srt:AsiaMember 2020-05-03 2021-01-30 0000065270 mei:AutomotiveMember 2020-05-03 2021-01-30 0000065270 mei:IndustrialMember 2020-05-03 2021-01-30 0000065270 mei:InterfaceMember 2020-05-03 2021-01-30 0000065270 mei:MedicalMember 2020-05-03 2021-01-30 0000065270 us-gaap:TransferredAtPointInTimeMember mei:AutomotiveMember 2020-05-03 2021-01-30 0000065270 us-gaap:TransferredAtPointInTimeMember mei:IndustrialMember 2020-05-03 2021-01-30 0000065270 us-gaap:TransferredAtPointInTimeMember mei:InterfaceMember 2020-05-03 2021-01-30 0000065270 us-gaap:TransferredAtPointInTimeMember mei:MedicalMember 2020-05-03 2021-01-30 0000065270 us-gaap:TransferredAtPointInTimeMember 2020-05-03 2021-01-30 0000065270 us-gaap:TransferredOverTimeMember mei:AutomotiveMember 2020-05-03 2021-01-30 0000065270 us-gaap:TransferredOverTimeMember 2020-05-03 2021-01-30 0000065270 srt:NorthAmericaMember mei:AutomotiveMember 2019-04-28 2020-02-01 0000065270 srt:NorthAmericaMember mei:IndustrialMember 2019-04-28 2020-02-01 0000065270 srt:NorthAmericaMember mei:InterfaceMember 2019-04-28 2020-02-01 0000065270 srt:NorthAmericaMember mei:MedicalMember 2019-04-28 2020-02-01 0000065270 srt:NorthAmericaMember 2019-04-28 2020-02-01 0000065270 srt:EuropeMember mei:AutomotiveMember 2019-04-28 2020-02-01 0000065270 srt:EuropeMember mei:IndustrialMember 2019-04-28 2020-02-01 0000065270 srt:EuropeMember mei:InterfaceMember 2019-04-28 2020-02-01 0000065270 srt:EuropeMember 2019-04-28 2020-02-01 0000065270 srt:AsiaMember mei:AutomotiveMember 2019-04-28 2020-02-01 0000065270 srt:AsiaMember mei:IndustrialMember 2019-04-28 2020-02-01 0000065270 srt:AsiaMember mei:InterfaceMember 2019-04-28 2020-02-01 0000065270 srt:AsiaMember 2019-04-28 2020-02-01 0000065270 mei:AutomotiveMember 2019-04-28 2020-02-01 0000065270 mei:IndustrialMember 2019-04-28 2020-02-01 0000065270 mei:InterfaceMember 2019-04-28 2020-02-01 0000065270 mei:MedicalMember 2019-04-28 2020-02-01 0000065270 us-gaap:TransferredAtPointInTimeMember mei:AutomotiveMember 2019-04-28 2020-02-01 0000065270 us-gaap:TransferredAtPointInTimeMember mei:IndustrialMember 2019-04-28 2020-02-01 0000065270 us-gaap:TransferredAtPointInTimeMember mei:InterfaceMember 2019-04-28 2020-02-01 0000065270 us-gaap:TransferredAtPointInTimeMember mei:MedicalMember 2019-04-28 2020-02-01 0000065270 us-gaap:TransferredAtPointInTimeMember 2019-04-28 2020-02-01 0000065270 us-gaap:TransferredOverTimeMember mei:AutomotiveMember 2019-04-28 2020-02-01 0000065270 us-gaap:TransferredOverTimeMember 2019-04-28 2020-02-01 0000065270 mei:CostOfProductsSoldMember 2020-11-01 2021-01-30 0000065270 mei:CostOfProductsSoldMember 2020-05-03 2021-01-30 0000065270 mei:SellingAndAdministrativeExpensesMember 2020-11-01 2021-01-30 0000065270 mei:SellingAndAdministrativeExpensesMember 2020-05-03 2021-01-30 0000065270 mei:EmployeeTerminationBenefitsMember 2020-02-03 2020-05-02 0000065270 mei:EmployeeTerminationBenefitsMember 2020-05-03 2021-01-30 0000065270 mei:EmployeeTerminationBenefitsMember us-gaap:CashMember 2020-05-03 2021-01-30 0000065270 mei:EmployeeTerminationBenefitsMember 2021-01-29 2021-01-30 0000065270 mei:AssetImpairmentChargesMember 2020-05-03 2021-01-30 0000065270 mei:AssetImpairmentChargesMember mei:NonCashMember 2020-05-03 2021-01-30 0000065270 us-gaap:ContractTerminationMember 2020-05-03 2021-01-30 0000065270 us-gaap:ContractTerminationMember 2021-01-29 2021-01-30 0000065270 2020-02-03 2020-05-02 0000065270 us-gaap:CashMember 2020-05-03 2021-01-30 0000065270 mei:NonCashMember 2020-05-03 2021-01-30 0000065270 2021-01-29 2021-01-30 0000065270 mei:EliminationsCorporateMember 2020-11-01 2021-01-30 0000065270 mei:EliminationsCorporateMember 2019-10-27 2020-02-01 0000065270 mei:EliminationsCorporateMember 2020-05-03 2021-01-30 0000065270 mei:EliminationsCorporateMember 2019-04-28 2020-02-01 xbrli:pure 0000065270 srt:MinimumMember us-gaap:BuildingAndBuildingImprovementsMember 2020-05-03 2021-01-30 0000065270 us-gaap:BuildingAndBuildingImprovementsMember srt:MaximumMember 2020-05-03 2021-01-30 0000065270 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2020-05-03 2021-01-30 0000065270 us-gaap:MachineryAndEquipmentMember srt:MaximumMember 2020-05-03 2021-01-30 0000065270 us-gaap:LandMember 2021-01-30 0000065270 us-gaap:LandMember 2020-05-02 0000065270 us-gaap:BuildingAndBuildingImprovementsMember 2021-01-30 0000065270 us-gaap:BuildingAndBuildingImprovementsMember 2020-05-02 0000065270 us-gaap:MachineryAndEquipmentMember 2021-01-30 0000065270 us-gaap:MachineryAndEquipmentMember 2020-05-02 0000065270 us-gaap:CurrencySwapMember 2020-04-14 2020-04-14 0000065270 us-gaap:CurrencySwapMember 2020-04-14 iso4217:EUR 0000065270 us-gaap:CurrencySwapMember 2021-01-30 0000065270 us-gaap:CurrencySwapMember 2020-05-02 0000065270 us-gaap:ForeignExchangeForwardMember 2021-01-30 0000065270 mei:AutomotiveMember 2020-05-02 0000065270 mei:IndustrialMember 2020-05-02 0000065270 mei:AutomotiveMember 2021-01-30 0000065270 mei:IndustrialMember 2021-01-30 0000065270 us-gaap:CustomerRelationshipsMember 2021-01-30 0000065270 mei:TradeNamesPatentsAndTechnologyLicencesMember 2021-01-30 0000065270 us-gaap:CustomerRelationshipsMember 2020-05-03 2021-01-30 0000065270 mei:TradeNamesPatentsAndTechnologyLicencesMember 2020-05-03 2021-01-30 0000065270 mei:TradeNamesPatentsAndTechnologyLicencesMember 2021-01-30 0000065270 us-gaap:CustomerRelationshipsMember 2020-05-02 0000065270 mei:TradeNamesPatentsAndTechnologyLicencesMember 2020-05-02 0000065270 us-gaap:CustomerRelationshipsMember 2019-05-03 2020-05-02 0000065270 mei:TradeNamesPatentsAndTechnologyLicencesMember 2019-05-03 2020-05-02 0000065270 mei:TradeNamesPatentsAndTechnologyLicencesMember 2020-05-02 0000065270 us-gaap:LineOfCreditMember us-gaap:RevolvingCreditFacilityMember 2021-01-30 0000065270 us-gaap:LineOfCreditMember us-gaap:RevolvingCreditFacilityMember 2020-05-02 0000065270 mei:TermLoanMember 2021-01-30 0000065270 mei:TermLoanMember 2020-05-02 0000065270 mei:OtherDebtMember 2021-01-30 0000065270 mei:OtherDebtMember 2020-05-02 0000065270 us-gaap:RevolvingCreditFacilityMember mei:BankofAmericaNAAndWellsFargoBankNAMember 2020-05-03 2021-01-30 0000065270 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember mei:BankofAmericaNAAndWellsFargoBankNAMember 2021-01-30 0000065270 us-gaap:RevolvingCreditFacilityMember mei:TermLoanMember mei:BankofAmericaNAAndWellsFargoBankNAMember 2021-01-30 0000065270 us-gaap:RevolvingCreditFacilityMember mei:BankofAmericaNAAndWellsFargoBankNAMember 2021-01-30 0000065270 us-gaap:RevolvingCreditFacilityMember mei:TermLoanMember mei:BankofAmericaNAAndWellsFargoBankNAMember 2020-05-03 2021-01-30 mei:note 0000065270 mei:OtherDebtMember 2020-05-03 2021-01-30 0000065270 us-gaap:RestrictedStockMember 2020-05-03 2021-01-30 0000065270 us-gaap:AccumulatedTranslationAdjustmentMember 2020-10-31 0000065270 us-gaap:AccumulatedTranslationAdjustmentMember 2019-10-26 0000065270 us-gaap:AccumulatedTranslationAdjustmentMember 2020-05-02 0000065270 us-gaap:AccumulatedTranslationAdjustmentMember 2019-04-27 0000065270 us-gaap:AccumulatedTranslationAdjustmentMember 2020-11-01 2021-01-30 0000065270 us-gaap:AccumulatedTranslationAdjustmentMember 2019-10-27 2020-02-01 0000065270 us-gaap:AccumulatedTranslationAdjustmentMember 2020-05-03 2021-01-30 0000065270 us-gaap:AccumulatedTranslationAdjustmentMember 2019-04-28 2020-02-01 0000065270 us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-30 0000065270 us-gaap:AccumulatedTranslationAdjustmentMember 2020-02-01 0000065270 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-10-31 0000065270 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-05-02 0000065270 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-11-01 2021-01-30 0000065270 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-05-03 2021-01-30 0000065270 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-01-30 0000065270 mei:TwoThousandFourteenStockPlanMember 2021-01-30 0000065270 us-gaap:PerformanceSharesMember 2020-11-01 2021-01-30 0000065270 srt:MinimumMember us-gaap:PerformanceSharesMember 2020-11-01 2021-01-30 0000065270 srt:MaximumMember us-gaap:PerformanceSharesMember 2020-11-01 2021-01-30 0000065270 us-gaap:PerformanceSharesMember 2021-01-30 0000065270 us-gaap:RestrictedStockUnitsRSUMember srt:MaximumMember 2020-11-01 2021-01-30 0000065270 us-gaap:RestrictedStockUnitsRSUMember 2020-11-01 2021-01-30 0000065270 us-gaap:RestrictedStockUnitsRSUMember 2021-01-30 0000065270 us-gaap:RestrictedStockUnitsRSUMember mei:TwoThousandFourteenStockPlanMember 2020-05-02 0000065270 us-gaap:RestrictedStockUnitsRSUMember mei:TwoThousandFourteenStockPlanMember 2020-05-03 2021-01-30 0000065270 us-gaap:RestrictedStockUnitsRSUMember mei:TwoThousandFourteenStockPlanMember 2021-01-30 0000065270 srt:DirectorMember us-gaap:RestrictedStockMember 2020-05-03 2021-01-30 0000065270 srt:DirectorMember us-gaap:RestrictedStockMember 2019-04-28 2020-02-01 0000065270 us-gaap:EmployeeStockOptionMember mei:TwoThousandTenAndTwoThousandSevenStockPlanMember 2020-05-02 0000065270 us-gaap:EmployeeStockOptionMember mei:TwoThousandTenAndTwoThousandSevenStockPlanMember 2020-05-03 2021-01-30 0000065270 us-gaap:EmployeeStockOptionMember mei:TwoThousandTenAndTwoThousandSevenStockPlanMember 2021-01-30 0000065270 mei:TwoThousandFourteenStockPlanMember us-gaap:PerformanceSharesMember srt:ManagementMember 2019-10-27 2020-02-01 0000065270 mei:TwoThousandFourteenStockPlanMember us-gaap:PerformanceSharesMember srt:ManagementMember 2019-04-28 2020-02-01 0000065270 mei:TwoThousandFourteenStockPlanMember us-gaap:RestrictedStockUnitsRSUMember srt:ManagementMember 2020-11-01 2021-01-30 0000065270 mei:TwoThousandFourteenStockPlanMember us-gaap:RestrictedStockUnitsRSUMember srt:ManagementMember 2019-10-27 2020-02-01 0000065270 mei:TwoThousandFourteenStockPlanMember us-gaap:RestrictedStockUnitsRSUMember srt:ManagementMember 2020-05-03 2021-01-30 0000065270 mei:TwoThousandFourteenStockPlanMember us-gaap:RestrictedStockUnitsRSUMember srt:ManagementMember 2019-04-28 2020-02-01 0000065270 mei:TwoThousandFourteenStockPlanMember us-gaap:RestrictedStockMember srt:DirectorMember 2020-05-03 2021-01-30 0000065270 mei:TwoThousandFourteenStockPlanMember us-gaap:RestrictedStockMember srt:DirectorMember 2019-04-28 2020-02-01 0000065270 mei:TwoThousandFourteenStockPlanMember 2020-11-01 2021-01-30 0000065270 mei:TwoThousandFourteenStockPlanMember 2019-10-27 2020-02-01 0000065270 mei:TwoThousandFourteenStockPlanMember 2019-04-28 2020-02-01 0000065270 us-gaap:OperatingSegmentsMember mei:AutomotiveMember 2020-11-01 2021-01-30 0000065270 us-gaap:OperatingSegmentsMember mei:IndustrialMember 2020-11-01 2021-01-30 0000065270 us-gaap:OperatingSegmentsMember mei:InterfaceMember 2020-11-01 2021-01-30 0000065270 us-gaap:OperatingSegmentsMember mei:MedicalMember 2020-11-01 2021-01-30 0000065270 us-gaap:OperatingSegmentsMember mei:CorporateAndIntersegmentEliminationMember 2020-11-01 2021-01-30 0000065270 us-gaap:OperatingSegmentsMember 2020-11-01 2021-01-30 0000065270 us-gaap:IntersegmentEliminationMember mei:AutomotiveMember 2020-11-01 2021-01-30 0000065270 us-gaap:IntersegmentEliminationMember mei:IndustrialMember 2020-11-01 2021-01-30 0000065270 us-gaap:IntersegmentEliminationMember mei:InterfaceMember 2020-11-01 2021-01-30 0000065270 us-gaap:IntersegmentEliminationMember mei:MedicalMember 2020-11-01 2021-01-30 0000065270 us-gaap:IntersegmentEliminationMember mei:CorporateAndIntersegmentEliminationMember 2020-11-01 2021-01-30 0000065270 us-gaap:IntersegmentEliminationMember 2020-11-01 2021-01-30 0000065270 mei:CorporateAndIntersegmentEliminationMember 2020-11-01 2021-01-30 0000065270 us-gaap:OperatingSegmentsMember mei:AutomotiveMember 2019-10-27 2020-02-01 0000065270 us-gaap:OperatingSegmentsMember mei:IndustrialMember 2019-10-27 2020-02-01 0000065270 us-gaap:OperatingSegmentsMember mei:InterfaceMember 2019-10-27 2020-02-01 0000065270 us-gaap:OperatingSegmentsMember mei:MedicalMember 2019-10-27 2020-02-01 0000065270 us-gaap:OperatingSegmentsMember mei:CorporateAndIntersegmentEliminationMember 2019-10-27 2020-02-01 0000065270 us-gaap:OperatingSegmentsMember 2019-10-27 2020-02-01 0000065270 us-gaap:IntersegmentEliminationMember mei:AutomotiveMember 2019-10-27 2020-02-01 0000065270 us-gaap:IntersegmentEliminationMember mei:IndustrialMember 2019-10-27 2020-02-01 0000065270 us-gaap:IntersegmentEliminationMember mei:InterfaceMember 2019-10-27 2020-02-01 0000065270 us-gaap:IntersegmentEliminationMember mei:MedicalMember 2019-10-27 2020-02-01 0000065270 us-gaap:IntersegmentEliminationMember mei:CorporateAndIntersegmentEliminationMember 2019-10-27 2020-02-01 0000065270 us-gaap:IntersegmentEliminationMember 2019-10-27 2020-02-01 0000065270 mei:CorporateAndIntersegmentEliminationMember 2019-10-27 2020-02-01 0000065270 us-gaap:OperatingSegmentsMember mei:AutomotiveMember 2020-05-03 2021-01-30 0000065270 us-gaap:OperatingSegmentsMember mei:IndustrialMember 2020-05-03 2021-01-30 0000065270 us-gaap:OperatingSegmentsMember mei:InterfaceMember 2020-05-03 2021-01-30 0000065270 us-gaap:OperatingSegmentsMember mei:MedicalMember 2020-05-03 2021-01-30 0000065270 us-gaap:OperatingSegmentsMember mei:CorporateAndIntersegmentEliminationMember 2020-05-03 2021-01-30 0000065270 us-gaap:OperatingSegmentsMember 2020-05-03 2021-01-30 0000065270 us-gaap:IntersegmentEliminationMember mei:AutomotiveMember 2020-05-03 2021-01-30 0000065270 us-gaap:IntersegmentEliminationMember mei:IndustrialMember 2020-05-03 2021-01-30 0000065270 us-gaap:IntersegmentEliminationMember mei:InterfaceMember 2020-05-03 2021-01-30 0000065270 us-gaap:IntersegmentEliminationMember mei:MedicalMember 2020-05-03 2021-01-30 0000065270 us-gaap:IntersegmentEliminationMember mei:CorporateAndIntersegmentEliminationMember 2020-05-03 2021-01-30 0000065270 us-gaap:IntersegmentEliminationMember 2020-05-03 2021-01-30 0000065270 mei:CorporateAndIntersegmentEliminationMember 2020-05-03 2021-01-30 0000065270 us-gaap:OperatingSegmentsMember mei:AutomotiveMember 2019-04-28 2020-02-01 0000065270 us-gaap:OperatingSegmentsMember mei:IndustrialMember 2019-04-28 2020-02-01 0000065270 us-gaap:OperatingSegmentsMember mei:InterfaceMember 2019-04-28 2020-02-01 0000065270 us-gaap:OperatingSegmentsMember mei:MedicalMember 2019-04-28 2020-02-01 0000065270 us-gaap:OperatingSegmentsMember mei:CorporateAndIntersegmentEliminationMember 2019-04-28 2020-02-01 0000065270 us-gaap:OperatingSegmentsMember 2019-04-28 2020-02-01 0000065270 us-gaap:IntersegmentEliminationMember mei:AutomotiveMember 2019-04-28 2020-02-01 0000065270 us-gaap:IntersegmentEliminationMember mei:IndustrialMember 2019-04-28 2020-02-01 0000065270 us-gaap:IntersegmentEliminationMember mei:InterfaceMember 2019-04-28 2020-02-01 0000065270 us-gaap:IntersegmentEliminationMember mei:MedicalMember 2019-04-28 2020-02-01 0000065270 us-gaap:IntersegmentEliminationMember mei:CorporateAndIntersegmentEliminationMember 2019-04-28 2020-02-01 0000065270 us-gaap:IntersegmentEliminationMember 2019-04-28 2020-02-01 0000065270 mei:CorporateAndIntersegmentEliminationMember 2019-04-28 2020-02-01 0000065270 mei:InterfaceMember 2021-01-30 0000065270 mei:InterfaceMember 2020-05-02 0000065270 mei:MedicalMember 2021-01-30 0000065270 mei:MedicalMember 2020-05-02 0000065270 mei:CorporateAndIntersegmentEliminationMember 2021-01-30 0000065270 mei:CorporateAndIntersegmentEliminationMember 2020-05-02 0000065270 mei:CompensatoryDamagesMember 2020-03-02 0000065270 mei:PunitiveDamagesMember 2020-03-02

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 10-Q

(Mark One)

☒ | Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

for the quarterly period ended January 30, 2021

or

☐ | Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

for the transition period from ______ to ______

Commission file number 001-33731

METHODE ELECTRONICS, INC.

(Exact name of registrant as specified in its charter)

Delaware | 36-2090085
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.)
8750 West Bryn Mawr Avenue, Suite 1000, Chicago, Illinois | 60631-3518
(Address of principal executive offices) | (Zip Code)

(Registrant’s telephone number, including area code) (708) 867-6777

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each Class |  | Trading Symbol(s) |  | Name of each exchange on which registered
Common Stock, $0.50 Par Value |  | MEI |  | New York Stock Exchange

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer.” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer |  | ☒ |  | Accelerated filer |  | ☐
Non-accelerated filer |  | ☐ |  | Smaller reporting company |  | ☐
Emerging Growth Company |  | ☐ |  |  |  |

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Securities Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

At March 1, 2021, the registrant had 38,446,738 shares of common stock outstanding.

Table of Contents

METHODE ELECTRONICS, INC.

INDEX

|  | Page
PART I. | FINANCIAL INFORMATION |
Item 1. | Financial Statements |
| Condensed Consolidated Statements of Income (unaudited) - Three and Nine Months Ended January 30, 2021 and February 1, 2020 | 2
| Condensed Consolidated Statements of Comprehensive Income (unaudited) - Three and Nine Months Ended January 30, 2021 and February 1, 2020 | 3
| Condensed Consolidated Balance Sheets as of January 30, 2021 (unaudited) and May 2, 2020 | 4
| Condensed Consolidated Statements of Shareholders' Equity (unaudited) - Three and Nine Months Ended January 30, 2021 and February 1, 2020 | 5
| Condensed Consolidated Statements of Cash Flows (unaudited) - Nine Months Ended January 30, 2021 and February 1, 2020 | 6
| Notes to Condensed Consolidated Financial Statements | 7
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 22
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 36
Item 4. | Controls and Procedures | 36
PART II. | OTHER INFORMATION |
Item 1A. | Risk Factors | 38
Item 6. | Exhibits | 39
SIGNATURES | 40

Table of Contents

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

METHODE ELECTRONICS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited)

(in millions, except per share data)

|  | Three Months Ended |  |  | Nine Months Ended |
|  | January 30, 2021 |  |  | February 1, 2020 |  |  | January 30, 2021 |  |  | February 1, 2020 |
|  | (13 Weeks) |  |  | (14 Weeks) |  |  | (39 Weeks) |  |  | (40 Weeks) |
Net Sales |  | $ | 295.3 |  |  | $ | 285.9 |  |  | $ | 787.0 |  |  | $ | 813.3 |
Cost of Products Sold |  |  | 222.7 |  |  |  | 206.6 |  |  |  | 588.5 |  |  |  | 589.6 |
Gross Profit |  |  | 72.6 |  |  |  | 79.3 |  |  |  | 198.5 |  |  |  | 223.7 |
Selling and Administrative Expenses |  |  | 32.4 |  |  |  | 33.0 |  |  |  | 89.8 |  |  |  | 98.6 |
Amortization of Intangibles |  |  | 4.8 |  |  |  | 4.8 |  |  |  | 14.5 |  |  |  | 14.3 |
Income from Operations |  |  | 35.4 |  |  |  | 41.5 |  |  |  | 94.2 |  |  |  | 110.8 |
Interest Expense, Net |  |  | 1.3 |  |  |  | 2.4 |  |  |  | 4.3 |  |  |  | 8.0 |
Other Income, Net |  |  | (2.4 | ) |  |  | (4.9 | ) |  |  | (8.4 | ) |  |  | (5.8 | )
Income before Income Taxes |  |  | 36.5 |  |  |  | 44.0 |  |  |  | 98.3 |  |  |  | 108.6 |
Income Tax Expense |  |  | 4.6 |  |  |  | 2.8 |  |  |  | 7.1 |  |  |  | 15.3 |
Net Income |  | $ | 31.9 |  |  | $ | 41.2 |  |  | $ | 91.2 |  |  | $ | 93.3 |
Basic and Diluted Income per Share: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | 0.84 |  |  | $ | 1.10 |  |  | $ | 2.40 |  |  | $ | 2.48 |
Diluted |  | $ | 0.83 |  |  | $ | 1.09 |  |  | $ | 2.39 |  |  | $ | 2.47 |
Cash Dividends per Share |  | $ | 0.11 |  |  | $ | 0.11 |  |  | $ | 0.33 |  |  | $ | 0.33 |

See notes to condensed consolidated financial statements.

2

Table of Contents

METHODE ELECTRONICS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)

(in millions)

|  | Three Months Ended |  |  | Nine Months Ended |
|  | January 30, 2021 |  |  | February 1, 2020 |  |  | January 30, 2021 |  |  | February 1, 2020 |
|  | (13 Weeks) |  |  | (14 Weeks) |  |  | (39 Weeks) |  |  | (40 Weeks) |
Net Income |  | $ | 31.9 |  |  | $ | 41.2 |  |  | $ | 91.2 |  |  | $ | 93.3 |
Other Comprehensive Income (Loss), Net of Tax: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Foreign Currency Translation Adjustments |  |  | 18.2 |  |  |  | 1.6 |  |  |  | 39.9 |  |  |  | (2.8 | )
Derivative Financial Instruments |  |  | (2.1 | ) |  |  | — |  |  |  | (4.8 | ) |  |  | — |
Total Comprehensive Income |  | $ | 48.0 |  |  | $ | 42.8 |  |  | $ | 126.3 |  |  | $ | 90.5 |

See notes to condensed consolidated financial statements.

3

Table of Contents

METHODE ELECTRONICS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(in millions, except share and per-share data)

|  | January 30, 2021 |  |  | May 2, 2020 |
|  | (Unaudited) |  |  |  |  |
ASSETS |  |  |  |  |  |  |  |
CURRENT ASSETS |  |  |  |  |  |  |  |
Cash and Cash Equivalents |  | $ | 218.7 |  |  | $ | 217.3 |
Accounts Receivable, Net |  |  | 278.5 |  |  |  | 188.5 |
Inventories |  |  | 124.0 |  |  |  | 131.0 |
Income Tax Receivable |  |  | 5.5 |  |  |  | 12.9 |
Prepaid Expenses and Other Current Assets |  |  | 18.3 |  |  |  | 15.9 |
TOTAL CURRENT ASSETS |  |  | 645.0 |  |  |  | 565.6 |
LONG-TERM ASSETS |  |  |  |  |  |  |  |
Property, Plant and Equipment, Net |  |  | 205.4 |  |  |  | 201.9 |
Goodwill |  |  | 234.8 |  |  |  | 231.6 |
Other Intangible Assets, Net |  |  | 233.7 |  |  |  | 244.8 |
Operating Lease Assets, Net |  |  | 23.3 |  |  |  | 23.5 |
Deferred Tax Assets |  |  | 41.9 |  |  |  | 31.4 |
Pre-production Costs |  |  | 22.6 |  |  |  | 37.1 |
Other Long-term Assets |  |  | 37.8 |  |  |  | 34.7 |
TOTAL LONG-TERM ASSETS |  |  | 799.5 |  |  |  | 805.0 |
TOTAL ASSETS |  | $ | 1,444.5 |  |  | $ | 1,370.6 |
LIABILITIES & SHAREHOLDERS' EQUITY |  |  |  |  |  |  |  |
CURRENT LIABILITIES |  |  |  |  |  |  |  |
Accounts Payable |  | $ | 117.8 |  |  | $ | 73.8 |
Accrued Employee Liabilities |  |  | 26.5 |  |  |  | 19.1 |
Other Accrued Liabilities |  |  | 32.9 |  |  |  | 18.5 |
Short-term Operating Lease Liability |  |  | 6.4 |  |  |  | 5.5 |
Short-term Debt |  |  | 15.4 |  |  |  | 15.3 |
Income Tax Payable |  |  | 10.2 |  |  |  | 11.6 |
TOTAL CURRENT LIABILITIES |  |  | 209.2 |  |  |  | 143.8 |
LONG-TERM LIABILITIES |  |  |  |  |  |  |  |
Long-term Debt |  |  | 229.2 |  |  |  | 336.8 |
Long-term Operating Lease Liability |  |  | 18.6 |  |  |  | 20.4 |
Long-term Income Tax Payable |  |  | 26.2 |  |  |  | 29.3 |
Other Long-term Liabilities |  |  | 21.6 |  |  |  | 15.3 |
Deferred Tax Liabilities |  |  | 42.1 |  |  |  | 41.6 |
TOTAL LONG-TERM LIABILITIES |  |  | 337.7 |  |  |  | 443.4 |
TOTAL LIABILITIES |  |  | 546.9 |  |  |  | 587.2 |
SHAREHOLDERS' EQUITY |  |  |  |  |  |  |  |
Common Stock, $0.50 par value, 100,000,000 shares authorized, 39,793,362 shares and 38,438,111 shares issued as of January 30, 2021 and May 2, 2020, respectively |  |  | 19.9 |  |  |  | 19.2 |
Additional Paid-in Capital |  |  | 154.4 |  |  |  | 150.7 |
Accumulated Other Comprehensive Income (Loss) |  |  | 8.2 |  |  |  | (26.9 | )
Treasury Stock, 1,346,624 shares as of January 30, 2021 and May 2, 2020 |  |  | (11.5 | ) |  |  | (11.5 | )
Retained Earnings |  |  | 726.6 |  |  |  | 651.9 |
TOTAL SHAREHOLDERS' EQUITY |  |  | 897.6 |  |  |  | 783.4 |
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY |  | $ | 1,444.5 |  |  | $ | 1,370.6 |

See notes to condensed consolidated financial statements.

4

Table of Contents

METHODE ELECTRONICS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (Unaudited)

(in millions, except share data)

|  | Three Months Ended January 30, 2021 (13 Weeks) |
|  | Common Stock Shares |  |  | Common Stock |  |  | Additional Paid-in Capital |  |  | Accumulated Other Comprehensive Income (Loss) |  |  | Treasury Stock |  |  | Retained Earnings |  |  | Total Equity |
Balance as of October 31, 2020 |  |  | 38,876,362 |  |  | $ | 19.4 |  |  | $ | 152.5 |  |  | $ | (7.9 | ) |  | $ | (11.5 | ) |  | $ | 698.9 |  |  | $ | 851.4 |
Issuance of Restricted Stock, Net of Tax Withholding |  |  | 917,000 |  |  |  | 0.5 |  |  |  | (0.5 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Stock-based Compensation Expense |  |  | — |  |  |  | — |  |  |  | 2.4 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 2.4 |
Other Comprehensive Income |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 16.1 |  |  |  | — |  |  |  | — |  |  |  | 16.1 |
Net Income |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 31.9 |  |  |  | 31.9 |
Dividends on Common Stock |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (4.2 | ) |  |  | (4.2 | )
Balance as of January 30, 2021 |  |  | 39,793,362 |  |  | $ | 19.9 |  |  | $ | 154.4 |  |  | $ | 8.2 |  |  | $ | (11.5 | ) |  | $ | 726.6 |  |  | $ | 897.6 |

|  | Three Months Ended February 1, 2020 (14 Weeks) |
|  | Common Stock Shares |  |  | Common Stock |  |  | Additional Paid-in Capital |  |  | Accumulated Other Comprehensive Income (Loss) |  |  | Treasury Stock |  |  | Retained Earnings |  |  | Total Equity |
Balance as of October 26, 2019 |  |  | 38,438,111 |  |  | $ | 19.2 |  |  | $ | 154.4 |  |  | $ | (18.0 | ) |  | $ | (11.5 | ) |  | $ | 588.5 |  |  | $ | 732.6 |
Stock-based Compensation Expense |  |  | — |  |  |  | — |  |  |  | 1.6 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 1.6 |
Other Comprehensive Income |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 1.6 |  |  |  | — |  |  |  | — |  |  |  | 1.6 |
Net Income |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 41.2 |  |  |  | 41.2 |
Dividends on Common Stock |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (4.1 | ) |  |  | (4.1 | )
Balance as of February 1, 2020 |  |  | 38,438,111 |  |  | $ | 19.2 |  |  | $ | 156.0 |  |  | $ | (16.4 | ) |  | $ | (11.5 | ) |  | $ | 625.6 |  |  | $ | 772.9 |

|  | Nine Months Ended January 30, 2021 (39 Weeks) |
|  | Common Stock Shares |  |  | Common Stock |  |  | Additional Paid-in Capital |  |  | Accumulated Other Comprehensive Income (Loss) |  |  | Treasury Stock |  |  | Retained Earnings |  |  | Total Equity |
Balance as of May 2, 2020 |  |  | 38,438,111 |  |  | $ | 19.2 |  |  | $ | 150.7 |  |  | $ | (26.9 | ) |  | $ | (11.5 | ) |  | $ | 651.9 |  |  | $ | 783.4 |
Issuance of Restricted Stock, Net of Tax Withholding |  |  | 1,350,251 |  |  |  | 0.7 |  |  |  | (0.7 | ) |  |  | — |  |  |  | — |  |  |  | (3.9 | ) |  |  | (3.9 | )
Exercise of Stock Options |  |  | 5,000 |  |  |  | — |  |  |  | 0.1 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 0.1 |
Stock-based Compensation Expense |  |  | — |  |  |  | — |  |  |  | 4.3 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 4.3 |
Other Comprehensive Income |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 35.1 |  |  |  | — |  |  |  | — |  |  |  | 35.1 |
Net Income |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 91.2 |  |  |  | 91.2 |
Dividends on Common Stock |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (12.6 | ) |  |  | (12.6 | )
Balance as of January 30, 2021 |  |  | 39,793,362 |  |  | $ | 19.9 |  |  | $ | 154.4 |  |  | $ | 8.2 |  |  | $ | (11.5 | ) |  | $ | 726.6 |  |  | $ | 897.6 |

|  | Nine Months Ended February 1, 2020 (40 Weeks) |
|  | Common Stock Shares |  |  | Common Stock |  |  | Additional Paid-in Capital |  |  | Accumulated Other Comprehensive Loss |  |  | Treasury Stock |  |  | Retained Earnings |  |  | Total Equity |
Balance as of April 27, 2019 |  |  | 38,333,576 |  |  | $ | 19.2 |  |  | $ | 150.4 |  |  | $ | (13.6 | ) |  | $ | (11.5 | ) |  | $ | 545.2 |  |  | $ | 689.7 |
Issuance of Restricted Stock, Net of Tax Withholding |  |  | 104,535 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (0.4 | ) |  |  | (0.4 | )
Stock-based Compensation Expense |  |  | — |  |  |  | — |  |  |  | 5.6 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 5.6 |
Other Comprehensive Loss |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (2.8 | ) |  |  | — |  |  |  | — |  |  |  | (2.8 | )
Net Income |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 93.3 |  |  |  | 93.3 |
Dividends on Common Stock |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (12.5 | ) |  |  | (12.5 | )
Balance as of February 1, 2020 |  |  | 38,438,111 |  |  | $ | 19.2 |  |  | $ | 156.0 |  |  | $ | (16.4 | ) |  | $ | (11.5 | ) |  | $ | 625.6 |  |  | $ | 772.9 |

See notes to condensed consolidated financial statements.

5

Table of Contents

METHODE ELECTRONICS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

(in millions)

|  | Nine Months Ended |
|  | January 30, 2021 |  |  | February 1, 2020 |
|  | (39 Weeks) |  |  | (40 Weeks) |
OPERATING ACTIVITIES |  |  |  |  |  |  |  |
Net Income |  | $ | 91.2 |  |  | $ | 93.3 |
Adjustments to Reconcile Net Income to Net Cash Provided by Operating Activities: |  |  |  |  |  |  |  |
Depreciation and Amortization |  |  | 38.2 |  |  |  | 36.0 |
Stock-based Compensation Expense |  |  | 4.3 |  |  |  | 5.6 |
Change in Cash Surrender Value of Life Insurance |  |  | (1.4 | ) |  |  | (0.6 | )
Amortization of Debt Issuance Costs |  |  | 0.5 |  |  |  | 0.5 |
Change in Deferred Income Taxes |  |  | (5.9 | ) |  |  | (0.4 | )
Other |  |  | 1.6 |  |  |  | 0.3 |
Changes in Operating Assets and Liabilities: |  |  |  |  |  |  |  |
Accounts Receivable |  |  | (77.1 | ) |  |  | (10.5 | )
Inventories |  |  | 11.8 |  |  |  | (9.9 | )
Prepaid Expenses and Other Assets |  |  | 21.3 |  |  |  | (12.8 | )
Accounts Payable and Other Liabilities |  |  | 59.3 |  |  |  | (18.9 | )
NET CASH PROVIDED BY OPERATING ACTIVITIES |  |  | 143.8 |  |  |  | 82.6 |
INVESTING ACTIVITIES |  |  |  |  |  |  |  |
Purchases of Property, Plant and Equipment |  |  | (20.1 | ) |  |  | (34.9 | )
Sale of Business/Investment/Property |  |  | 0.1 |  |  |  | 0.5 |
NET CASH USED IN INVESTING ACTIVITIES |  |  | (20.0 | ) |  |  | (34.4 | )
FINANCING ACTIVITIES |  |  |  |  |  |  |  |
Taxes Paid Related to Net Share Settlement of Equity Awards |  |  | (3.9 | ) |  |  | (0.4 | )
Proceeds from Exercise of Stock Options |  |  | 0.1 |  |  |  | — |
Repayments of Finance Leases |  |  | (0.4 | ) |  |  | (0.5 | )
Cash Dividends |  |  | (13.2 | ) |  |  | (12.2 | )
Proceeds from Borrowings |  |  | 1.5 |  |  |  | 57.3 |
Repayments of Borrowings |  |  | (111.9 | ) |  |  | (93.9 | )
NET CASH USED IN FINANCING ACTIVITIES |  |  | (127.8 | ) |  |  | (49.7 | )
Effect of Foreign Currency Exchange Rate Changes on Cash and Cash Equivalents |  |  | 5.4 |  |  |  | (1.8 | )
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS |  |  | 1.4 |  |  |  | (3.3 | )
Cash and Cash Equivalents at Beginning of the Year |  |  | 217.3 |  |  |  | 83.2 |
CASH AND CASH EQUIVALENTS AT END OF THE PERIOD |  | $ | 218.7 |  |  | $ | 79.9 |
SUPPLEMENTAL CASH FLOW INFORMATION |  |  |  |  |  |  |  |
Cash Paid During the Period For: |  |  |  |  |  |  |  |
Interest |  | $ | 4.3 |  |  | $ | 7.6 |
Income Taxes, Net of Refunds |  | $ | 9.6 |  |  | $ | 16.2 |
Operating Lease Obligations |  | $ | 6.7 |  |  | $ | 6.5 |

See notes to condensed consolidated financial statements.

6

Table of Contents

METHODE ELECTRONICS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

Note 1. | Description of Business and Summary of Significant Accounting Policies

Description of Business

Methode Electronics, Inc. (the "Company" or "Methode") is a global developer of custom engineered and application specific products and solutions with manufacturing, design and testing facilities in Belgium, Canada, China, Egypt, Germany, India, Italy, Lebanon, Malta, Mexico, the Netherlands, Singapore, Switzerland, the United Kingdom and the United States. The Company's primary manufacturing facilities are located in Dongguan and Shanghai, China; Cairo, Egypt; Mriehel, Malta; and Monterrey, Mexico. The Company designs, manufactures and markets devices employing electrical, electronic, LED lighting, sensors and radio remote control technologies.

Impact of COVID-19

The COVID-19 pandemic has negatively affected the global economy, disrupted global supply chains, and created significant volatility and disruptions to capital and credit markets in the global financial markets. The Company began to see the impacts of the COVID-19 pandemic at the beginning of its fourth quarter of fiscal 2020 at its China manufacturing facilities, which were initially closed after the Chinese New Year. The Company’s manufacturing facilities in China resumed operations later in the fourth quarter of fiscal 2020, but at lower capacity utilization. However, the major impact to the Company’s business from the COVID-19 pandemic began in mid-March 2020, as the Company’s operations in North America and Europe were adversely impacted by many customers suspending their manufacturing operations due to the COVID-19 pandemic. In the first quarter of fiscal 2021, the Company’s operations in North America and Europe gradually resumed operations, however production levels were still significantly reduced, resulting in lower capacity utilization. In the second quarter of fiscal 2021, production levels returned to pre-COVID levels as a result of increased demand from customers, which continued in the third quarter of fiscal 2021. However, towards the end of the Company’s third quarter of fiscal 2021, many automotive companies announced a slowdown in their production schedules due to a worldwide semiconductor supply shortage. The semiconductor supply shortage is also impacting the Company’s supply chain and its ability to meet demand at some of its non-automotive customers. The Company expects this semiconductor shortage will likely have a short-term impact on its operating results and financial condition in the fourth quarter of fiscal 2021 and possibly into fiscal 2022.

Various government programs have been enacted to provide assistance to businesses impacted by the COVID-19 pandemic. The amount of assistance the Company received was $2.7 million and $8.9 million in the three and nine months ended January 30, 2021, respectively, and has been reported as other income.

The Company assessed certain accounting matters that require consideration of forecasted financial information, including, but not limited to, its allowance for credit losses, the carrying value of the Company's goodwill, identifiable intangible assets, and other long-lived assets, and valuation allowances in context with the information reasonably available to the Company and the unknown future impacts of the COVID-19 pandemic as of January 30, 2021 and through the date of this report. As a result of these assessments, the Company concluded that there were no impairments or material increases in credit allowances or valuation allowances that impacted the Company's condensed consolidated financial statements as of January 30, 2021 and for the three and nine months ended January 30, 2021. However, the Company's future assessment of the magnitude and duration of the COVID-19 pandemic, as well as other factors, could result in material impacts to its consolidated financial statements in future reporting periods.

At this time, the ultimate impact of the COVID-19 pandemic cannot be reasonably estimated due to the uncertainty about the extent and duration of the spread of the virus. Therefore, it is possible the COVID-19 pandemic could still have an adverse impact on the Company’s future business, operating results and financial condition.

Basis of Presentation

The unaudited condensed consolidated financial statements of the Company have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission ("SEC"). All intercompany balances and transactions have been eliminated in consolidation. Certain information and footnote disclosures normally included in financial statements prepared in

7

Table of Contents

accordance with accounting principles generally accepted in the United States ("GAAP") have been condensed or omitted pursuant to such rules and regulations. These interim condensed consolidated financial statements include all adjustments (consisting of normal recurring adjustments, except as otherwise disclosed) that management believes are necessary for a fair presentation of the results of operations, financial position and cash flows of the Company for the interim periods presented. These financial statements should be read in conjunction with the consolidated financial statements included in the Company's Form 10-K for the year ended May 2, 20 20, filed with the SEC on June 30, 20 20. Results may vary from quarter-to-quarter for reasons other than seasonality.

Financial Reporting Periods

The Company maintains its financial records on the basis of a 52- or 53-week fiscal year ending on the Saturday closest to April 30. Fiscal 2021 is a 52-week year and fiscal 2020 was a 53-week year. For the three months ended January 30, 2021, the Company’s accounting period included 13 weeks compared to 14 weeks for the three months ended February 1, 2020. For the nine months ended January 30, 2021, the Company’s accounting period included 39 weeks compared to 40 weeks for the nine months ended February 1, 2020. The following discussions of comparative results should be reviewed in this context.

Use of Estimates

The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results could differ from these estimates.

Summary of Significant Accounting Policies

The Company’s significant accounting policies are described in Note 1, "Description of Business and Summary of Significant Accounting Policies," to the consolidated financial statements included in the Company's Form 10-K for the year ended May 2, 2020. There have been no material changes to the significant accounting policies in the nine months ended January 30, 2021 other than those noted below.

Recently Adopted Accounting Pronouncements

In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-13, “Financial Instruments-Credit Losses (Topic 326) - Measurement of Credit Losses on Financial Instruments.” The guidance in ASU 2016-13 requires the measurement and recognition of expected credit losses for financial assets held at amortized cost. It replaces the existing incurred loss impairment model with an expected loss methodology, which will result in more timely recognition of credit losses.

The Company adopted this guidance as of May 3, 2020. The guidance allows for various methods for measuring expected credit losses. The Company elected to apply a historical loss rate based on historic write-offs to aging categories. The historical loss rate will be adjusted for current conditions and reasonable and supportable forecasts of future losses as necessary. The adoption of the guidance did not have a material impact on the Company's condensed consolidated financial statements. The allowance for doubtful accounts balance was $0.8 million and $0.6 million as of January 30, 2021 and May 2, 2020, respectively.

In August 2018, the FASB issued ASU 2018-15, "Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract." The guidance in ASU 2018-15 clarifies the accounting for implementation costs in cloud computing arrangements. The Company adopted this guidance prospectively as of May 3, 2020, and the impact on its condensed consolidated financial statements will depend on the nature of the Company’s future cloud computing arrangements.

In August 2018, the FASB issued ASU 2018-13, “Fair Value Measurement (Topic 820) – Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement." The guidance in ASU 2018-13 changes disclosure requirements related to fair value measurements as part of the disclosure framework project. The disclosure framework project aims to improve the effectiveness of disclosures in the notes to the financial statements by focusing on requirements that clearly communicate the most important information to users of the financial statements. The Company adopted this guidance as of May 3, 2020, and there was no impact on the condensed consolidated financial statements.

8

Table of Contents

In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” ASU 2020-04 provides optional expedients and exceptions for applying GAAP to contract modifications and hedging relationships that reference LIBOR or another rate that is expected to be discontinued, subject to meeting certain criteria. ASU 2020-04 was effective upon issuance and generally can be applied prospectively through December 31, 2022. The Company does not expect a material effect from the adoption of this guidance on its cond ensed consolidated financial statements.

New Accounting Pronouncements Not Yet Adopted

In December 2019, the FASB issued ASU 2019-12, "Income Taxes - Simplifying the Accounting for Income Taxes (Topic 740)," which simplifies the accounting for income taxes. The new guidance removes certain exceptions to the general principles in Accounting Standards Codification (“ASC”) 740, such as recognizing deferred taxes for equity investments, the incremental approach to performing intraperiod tax allocation and calculating income taxes in interim periods. The standard also simplifies accounting for income taxes under GAAP by clarifying and amending existing guidance, including the recognition of deferred taxes for goodwill, the allocation of taxes to members of a consolidated group and requiring that an entity reflect the effect of enacted changes in tax laws or rates in the annual effective tax rate computation in the interim period that includes the enactment date. This guidance is effective for annual periods beginning after December 15, 2020, and interim periods thereafter; however, early adoption is permitted. The Company is currently assessing the potential impact of the standard on its condensed consolidated financial statements.

Note 2. | Revenue

The majority of the Company's revenue is recognized at a point in time. The Company has determined that the most definitive demonstration that control has transferred to a customer is physical shipment or delivery, depending on the contractual shipping terms, except for consignment transactions. Consignment transactions are arrangements where the Company transfers product to a customer location but retains ownership and control of such product until it is used by the customer. Revenue for consignment arrangements is recognized upon the customer’s usage.

Revenues associated with products which the Company believes have no alternative use, and where the Company has an enforceable right to payment, are recognized on an over time basis. The Company believes the most faithful depiction of the transfer of goods to the customer is based on progress to date, which is typically smooth throughout the production process. As such, the Company recognizes revenue evenly over the production process through transfer of control to the customer.

Customers typically negotiate annual price downs. Management has evaluated these price downs and determined that in some instances, these price downs give rise to a material right. In instances that a material right exists, a portion of the transaction price is allocated to the material right and recognized over the life of the contract.

The Company treats shipping and handling costs as an activity necessary to fulfill the performance obligation to transfer product to the customer and not as a separate performance obligation.

Across all products, the amount of revenue recognized corresponds to the related purchase order. Sales and other taxes collected concurrent with revenue-producing activities are excluded from revenue.

Contract Balances

A contract asset is an entity’s right to consideration in exchange for goods or services that the entity has transferred to a customer. A contract liability exists when an entity has received consideration, or the amount is due from the customer in advance of revenue recognition. The net changes in the contract asset and contract liability balances for the three and nine months ended January 30, 2021 and February 1, 2020 were not material.

9

Table of Contents

Disaggregated Revenue Information

Geographic net sales are determined based on the Company's operational locations. Though revenue recognition patterns and contract provisions are generally consistent, the amount, timing and uncertainty of revenue and cash flows may vary in each reportable segment due to geographic and economic factors.

|  | Three Months Ended January 30, 2021 (13 Weeks) |
(Dollars in Millions) |  | Auto |  |  | Industrial |  |  | Interface |  |  | Medical |  |  | Total |
Geographic Net Sales: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
North America |  | $ | 107.7 |  |  | $ | 36.6 |  |  | $ | 17.4 |  |  | $ | 0.7 |  |  | $ | 162.4 |
Europe & Africa |  |  | 60.1 |  |  |  | 18.0 |  |  |  | — |  |  |  | — |  |  |  | 78.1 |
Asia |  |  | 42.7 |  |  |  | 11.9 |  |  |  | 0.2 |  |  |  | — |  |  |  | 54.8 |
Total Net Sales |  | $ | 210.5 |  |  | $ | 66.5 |  |  | $ | 17.6 |  |  | $ | 0.7 |  |  | $ | 295.3 |
Timing of Revenue Recognition: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Goods Transferred at a Point in Time |  | $ | 198.9 |  |  | $ | 66.5 |  |  | $ | 17.6 |  |  | $ | 0.7 |  |  | $ | 283.7 |
Goods Transferred Over Time |  |  | 11.6 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 11.6 |
Total Net Sales |  | $ | 210.5 |  |  | $ | 66.5 |  |  | $ | 17.6 |  |  | $ | 0.7 |  |  | $ | 295.3 |

|  | Three Months Ended February 1, 2020 (14 Weeks) |
(Dollars in Millions) |  | Auto |  |  | Industrial |  |  | Interface |  |  | Medical |  |  | Total |
Geographic Net Sales: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
North America |  | $ | 130.3 |  |  | $ | 38.4 |  |  | $ | 14.6 |  |  | $ | 0.6 |  |  | $ | 183.9 |
Europe & Africa |  |  | 57.2 |  |  |  | 12.2 |  |  |  | 0.1 |  |  |  | — |  |  |  | 69.5 |
Asia |  |  | 22.8 |  |  |  | 9.5 |  |  |  | 0.2 |  |  |  | — |  |  |  | 32.5 |
Total Net Sales |  | $ | 210.3 |  |  | $ | 60.1 |  |  | $ | 14.9 |  |  | $ | 0.6 |  |  | $ | 285.9 |
Timing of Revenue Recognition: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Goods Transferred at a Point in Time |  | $ | 198.6 |  |  | $ | 60.1 |  |  | $ | 14.9 |  |  | $ | 0.6 |  |  | $ | 274.2 |
Goods Transferred Over Time |  |  | 11.7 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 11.7 |
Total Net Sales |  | $ | 210.3 |  |  | $ | 60.1 |  |  | $ | 14.9 |  |  | $ | 0.6 |  |  | $ | 285.9 |

|  | Nine Months Ended January 30, 2021 (39 Weeks) |
(Dollars in Millions) |  | Auto |  |  | Industrial |  |  | Interface |  |  | Medical |  |  | Total |
Geographic Net Sales: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
North America |  | $ | 301.8 |  |  | $ | 99.0 |  |  | $ | 46.8 |  |  | $ | 1.9 |  |  | $ | 449.5 |
Europe & Africa |  |  | 147.1 |  |  |  | 47.5 |  |  |  | — |  |  |  | — |  |  |  | 194.6 |
Asia |  |  | 102.4 |  |  |  | 39.9 |  |  |  | 0.6 |  |  |  | — |  |  |  | 142.9 |
Total Net Sales |  | $ | 551.3 |  |  | $ | 186.4 |  |  | $ | 47.4 |  |  | $ | 1.9 |  |  | $ | 787.0 |
Timing of Revenue Recognition: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Goods Transferred at a Point in Time |  | $ | 525.7 |  |  | $ | 186.4 |  |  | $ | 47.4 |  |  | $ | 1.9 |  |  | $ | 761.4 |
Goods Transferred Over Time |  |  | 25.6 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 25.6 |
Total Net Sales |  | $ | 551.3 |  |  | $ | 186.4 |  |  | $ | 47.4 |  |  | $ | 1.9 |  |  | $ | 787.0 |

|  | Nine Months Ended February 1, 2020 (40 Weeks) |
(Dollars in Millions) |  | Auto |  |  | Industrial |  |  | Interface |  |  | Medical |  |  | Total |
Geographic Net Sales: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
North America |  | $ | 358.6 |  |  | $ | 133.2 |  |  | $ | 38.9 |  |  | $ | 1.2 |  |  | $ | 531.9 |
Europe & Africa |  |  | 158.9 |  |  |  | 36.6 |  |  |  | 0.3 |  |  |  | — |  |  |  | 195.8 |
Asia |  |  | 59.1 |  |  |  | 26.0 |  |  |  | 0.5 |  |  |  | — |  |  |  | 85.6 |
Total Net Sales |  | $ | 576.6 |  |  | $ | 195.8 |  |  | $ | 39.7 |  |  | $ | 1.2 |  |  | $ | 813.3 |
Timing of Revenue Recognition: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Goods Transferred at a Point in Time |  | $ | 546.3 |  |  | $ | 195.8 |  |  | $ | 39.7 |  |  | $ | 1.2 |  |  | $ | 783.0 |
Goods Transferred Over Time |  |  | 30.3 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 30.3 |
Total Net Sales |  | $ | 576.6 |  |  | $ | 195.8 |  |  | $ | 39.7 |  |  | $ | 1.2 |  |  | $ | 813.3 |

10

Table of Contents

Note 3. | Restructuring

The Company continually monitors market factors and industry trends and takes necessary actions to reduce overall costs and improve operational profitability. In the three and nine months ended January 30, 2021, the Company initiated certain restructuring actions in response to the adverse impacts from the COVID-19 pandemic. These actions included plant consolidations and workforce reductions in the Automotive, Industrial and Interface segments. In the three months ended January 30, 2021, the Company recognized $0.7 million of restructuring costs. These charges consist of $0.4 million recorded in cost of products sold and $0.3 million recorded in selling and administrative expenses. In the nine months ended January 30, 2021, the Company recognized $8.3 million of restructuring costs. These charges consist of $5.0 million recorded in cost of products sold and $3.3 million recorded in selling and administrative expenses.

Employee termination benefits are accrued upon the commitment to a termination plan and when the benefit arrangement is communicated to affected employees, or when liabilities are determined to be probable and estimable. Asset impairment charges relate to the impairment of right-of-use lease assets and equipment. Contract termination costs are recorded when notification of termination is given to the other party. The following is a rollforward of the Company's restructuring activity for the nine months ended January 30, 2021:

|  |  |  |  |  |  |  |  |  | Utilization |  |  |  |  |
(Dollars in Millions) |  | Accrual as of May 2, 2020 |  |  | YTD Charges |  |  | Cash |  |  | Non-cash |  |  | Accrual as of January 30, 2021 |
Employee Termination Benefits |  | $ | 0.2 |  |  | $ | 7.1 |  |  | $ | (6.5 | ) |  | $ | — |  |  | $ | 0.8 |
Asset Impairment Charges |  |  | — |  |  |  | 0.6 |  |  |  | — |  |  |  | (0.6 | ) |  |  | — |
Contract Termination Costs |  |  | — |  |  |  | 0.6 |  |  |  | — |  |  |  | — |  |  |  | 0.6 |
Total |  | $ | 0.2 |  |  | $ | 8.3 |  |  | $ | (6.5 | ) |  | $ | (0.6 | ) |  | $ | 1.4 |

The table below presents restructuring costs by reportable segment:

|  | Three Months Ended |  |  | Nine Months Ended |
|  | January 30, 2021 |  |  | February 1, 2020 |  |  | January 30, 2021 |  |  | February 1, 2020 |
(Dollars in Millions) |  | (13 Weeks) |  |  | (14 Weeks) |  |  | (39 Weeks) |  |  | (40 Weeks) |
Automotive |  | $ | 0.5 |  |  | $ | 0.5 |  |  | $ | 6.4 |  |  | $ | 0.7 |
Industrial |  |  | — |  |  |  | 0.2 |  |  |  | 0.9 |  |  |  | 0.4 |
Interface |  |  | — |  |  |  | — |  |  |  | 0.7 |  |  |  | — |
Medical |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 0.1 |
Eliminations/Corporate |  |  | 0.2 |  |  |  | 0.4 |  |  |  | 0.3 |  |  |  | 0.4 |
Total Restructuring Costs |  | $ | 0.7 |  |  | $ | 1.1 |  |  | $ | 8.3 |  |  | $ | 1.6 |

Estimates of restructuring costs are based on information available at the time such charges are recorded. Due to the inherent uncertainty involved in estimating restructuring costs, actual amounts paid for such activities may differ from amounts initially recorded. Accordingly, the Company may record revisions of previous estimates by adjusting previously established accruals. The Company expects to incur additional restructuring costs of approximately $0.2 million during the current fiscal year related to the initiated restructuring programs and may take additional restructuring actions in future periods based upon market conditions and industry trends.

Note 4. | Income Taxes

The provision for income taxes for an interim period is based on an estimated annual effective income tax rate and this rate is applied to ordinary year-to-date earnings or losses. The estimated annual effective income tax rate is determined excluding the effects of unusual or significant one-time items that are reported net of the related tax effects in the period in which they occur. In addition,

11

Table of Contents

any material effects of enacted tax law or rate changes as well as the Company’s ability to utilize various tax assets is recognized in the period in which the change occurs.

The computation of the estimated annual effective income tax rate at each interim period requires certain estimates and

assumptions including, but not limited to, the expected pre-tax income (or loss) for the year by jurisdiction, certain book to tax adjustments, and the likelihood of the realizability of deferred tax assets generated in the current year. The volatile global economic conditions resulting from the COVID-19 pandemic, the impacts of which are difficult to predict, may cause fluctuations in the Company’s expected pre-tax income (or loss) for the year, which could create volatility in the estimated annual effective income tax rate. The estimates used to compute the provision or benefit for income taxes may change as new events occur, additional information is obtained or as the Company’s tax environment changes.

The Company’s income tax expense and effective tax rate for the three and nine months ended January 30, 2021 and February 1, 2020 were as follows:

|  | Three Months Ended |  |  | Nine Months Ended |
|  | January 30, 2021 |  |  | February 1, 2020 |  |  | January 30, 2021 |  |  | February 1, 2020 |
(Dollars in Millions) |  | (13 Weeks) |  |  | (14 Weeks) |  |  | (39 Weeks) |  |  | (40 Weeks) |
Income before Income Taxes |  | $ | 36.5 |  |  | $ | 44.0 |  |  | $ | 98.3 |  |  | $ | 108.6 |
Income Tax Expense |  | $ | 4.6 |  |  | $ | 2.8 |  |  | $ | 7.1 |  |  | $ | 15.3 |
Effective Tax Rate |  |  | 12.6 | % |  |  | 6.4 | % |  |  | 7.2 | % |  |  | 14.1 | %

The income tax provision for the three months ended January 30, 2021 was lower than the U.S. statutory tax rate primarily due to foreign operations with lower statutory tax rates. The income tax provision for the nine months ended January 30, 2021 benefited from various tax credits earned in foreign jurisdictions and foreign operations with lower statutory tax rates. The income tax provision for both the three and nine months ended February 1, 2020 was lower than the U.S. statutory tax rate primarily due to beneficial changes related to U.S. Tax Reform and foreign operations with lower statutory rates.

The Company's unrecognized income tax benefits were $5.2 million as of both January 30, 2021 and May 2, 2020. If any portion of the Company’s unrecognized tax benefits is recognized, it would impact the Company’s effective tax rate. The unrecognized tax benefits are reviewed periodically and adjusted for changing facts and circumstances, such as tax audits, lapse of applicable statutes of limitations and changes in tax law.

Note 5.Balance Sheet Components

Inventories

Inventories are stated at the lower-of-cost or net realizable value. Cost is determined using the first-in, first-out method. Finished products and work-in-process inventories include direct material costs and direct and indirect manufacturing costs. The Company records reserves for inventory that may be obsolete or in excess of current and future market demand. A summary of inventories is shown below:

(Dollars in Millions) |  | January 30, 2021 |  |  | May 2, 2020 |
Finished Products |  | $ | 25.0 |  |  | $ | 45.7 |
Work in Process |  |  | 12.9 |  |  |  | 10.8 |
Raw Materials |  |  | 86.1 |  |  |  | 74.5 |
Total Inventories |  | $ | 124.0 |  |  | $ | 131.0 |

12

Table of Contents

Property, Plant and Equipment

Property, plant and equipment is stated at cost. Maintenance and repair costs are expensed as incurred. Depreciation is calculated using the straight-line method using estimated useful lives of 5 to 40 years for buildings and building improvements and 3 to 15 years for machinery and equipment. A summary of property, plant and equipment is shown below:

(Dollars in Millions) |  | January 30, 2021 |  |  | May 2, 2020 |
Land |  | $ | 3.4 |  |  | $ | 3.3 |
Buildings and Building Improvements |  |  | 84.5 |  |  |  | 87.3 |
Machinery and Equipment |  |  | 440.6 |  |  |  | 412.3 |
Total Property, Plant and Equipment, Gross |  |  | 528.5 |  |  |  | 502.9 |
Less: Accumulated Depreciation |  |  | (323.1 | ) |  |  | (301.0 | )
Property, Plant and Equipment, Net |  | $ | 205.4 |  |  | $ | 201.9 |

Depreciation expense was $8.7 million and $7.5 million in the three months ended January 30, 2021 and February 1, 2020, respectively. Depreciation expense was $23.7 million and $21.7 million in the nine months ended January 30, 2021 and February 1, 2020, respectively. As of January 30, 2021 and May 2, 2020, capital expenditures recorded in accounts payable totaled $1.1 million and $5.8 million, respectively.

Pre-Production Tooling Costs Related to Long-term Supply Arrangements

The Company incurs pre-production tooling costs related to certain products produced for its customers under long-term supply arrangements. As of January 30, 2021 and May 2, 2020, the Company had $22.6 million and $37.1 million, respectively, of pre-production tooling costs related to customer-owned tools for which reimbursement is contractually guaranteed by the customer or for which the customer has provided a non-cancelable right to use the tooling. Engineering, testing and other costs incurred in the design and development of production parts are expensed as incurred, unless the costs are reimbursable, as specified in a customer contract. As of January 30, 2021 and May 2, 2020, the Company had $16.3 million and $19.0 million, respectively, of Company owned pre-production tooling, which is capitalized within property, plant and equipment.

Derivative Instruments and Hedging Activities

The Company is exposed to foreign currency risks that arise from normal business operations. The Company strives to control its exposure to these risks through our normal operating activities and, where appropriate, through derivative instruments. The Company does not hold derivative instruments for trading or speculative purposes.

The Company recognizes derivative instruments as either assets or liabilities in the condensed consolidated balance sheets at fair value and classifies the derivatives within Level 2 in the fair value hierarchy.

Net Investment Hedges

In April 2020, the Company entered into a variable-rate, cross-currency swap, maturing on August 31, 2023, with a

notional value of $60.0 million (€54.8 million). The cross-currency swap is designated as a hedge of the Company's net investment in a euro-based subsidiary. The Company entered into the cross-currency swap to mitigate changes in net assets due to changes in U.S.

dollar-euro spot exchange rates. The cross-currency swap was in a liability position with an aggregate fair value of $7.5 million and $1.3 million as of January 30, 2021 and May 2, 2020, respectively, and is recorded within other long-term liabilities in the condensed consolidated balance sheets. Hedge effectiveness is assessed at the inception of the hedging relationship and quarterly thereafter, under the spot-to-spot method. The Company records changes in fair value attributable to the translation of foreign currencies through accumulated other comprehensive income (loss). The Company recognizes the impact of all other changes in fair value of the derivative through interest expense, which was not material in the three and nine months ended January 30, 2021.

Derivatives Not Designated as Hedges

In January 2021, the Company began to use short-term foreign currency forward contracts to reduce the earnings impact that exchange rate fluctuations have on non-functional currency balance sheet exposures. These forward contracts are not designated as

13

Table of Contents

hedging instruments. Gains and losses on these forward co ntracts are recognized in other income (expense), net, along with the foreign currency gains and losses on monetary assets and liabilities in the condensed consolidated statements of income.

As of January 30, 2021, the Company held foreign currency forward contracts with a notional value of $21.9 million. The forward contracts were in a liability position with an aggregate fair value of $0.2 million as of January 30, 2021 and are recorded within other accrued liabilities in the condensed consolidated balance sheets. During both the three and nine months ended January 30, 2021, losses of $0.2 million were recorded in earnings within other income (expense), net in the condensed consolidated statements of income.

Note 6.Goodwill and Other Intangible Assets

Goodwill

A summary of the changes in the carrying amount of goodwill, by segment, is shown below:

(Dollars in Millions) |  | Automotive |  |  | Industrial |  |  | Total |
Balance as of May 2, 2020 |  | $ | 106.2 |  |  | $ | 125.4 |  |  | $ | 231.6 |
Foreign Currency Translation |  |  | 0.6 |  |  |  | 2.6 |  |  |  | 3.2 |
Balance as of January 30, 2021 |  | $ | 106.8 |  |  | $ | 128.0 |  |  | $ | 234.8 |

The Company tests indefinite-lived intangible assets and goodwill for impairment by either performing a qualitative evaluation or a quantitative test at least annually, or more frequently if an indication of impairment arises. The qualitative evaluation is an assessment of factors to determine whether it is more likely than not that the fair value of a reporting unit or asset is less than its carrying amount.

During the third quarter of fiscal 2021, the Company evaluated the effects of the COVID-19 pandemic and its negative impact on the global economy on each of the Company’s reporting units and indefinite-lived intangible assets. Management reviewed key assumptions, including revisions of projected future revenues for reporting units and the results of the previous annual impairment testing performed during the fourth quarter of fiscal 2020. The Company did not identify an indication of impairment for any of its reporting units or indefinite-lived intangible assets. Although it was determined that a triggering event had not occurred as of January 30, 2021, management will continue to monitor the impacts of the COVID-19 pandemic on the Company and significant changes in key assumptions that could result in future period impairment charges.

Other Intangible Assets, Net

Details of identifiable intangible assets are shown below:

|  | As of January 30, 2021 |
(Dollars in Millions) |  | Gross |  |  | Accumulated Amortization |  |  | Net |  |  | Wtd. Avg. Remaining Amortization Periods (Years) |
Definite-lived Intangible Assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Customer Relationships and Agreements |  | $ | 246.7 |  |  | $ | (51.2 | ) |  | $ | 195.5 |  |  |  | 15.8 |
Trade Names, Patents and Technology Licenses |  |  | 76.1 |  |  |  | (39.7 | ) |  |  | 36.4 |  |  |  | 7.2 |
Total Definite-lived Intangible Assets |  |  | 322.8 |  |  |  | (90.9 | ) |  |  | 231.9 |  |  |  |  |
Indefinite-lived Intangible Assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Trade Names, Patents and Technology Licenses |  |  | 1.8 |  |  |  | — |  |  |  | 1.8 |  |  |  |  |
Total Indefinite-lived Intangible Assets |  |  | 1.8 |  |  |  | — |  |  |  | 1.8 |  |  |  |  |
Total Other Intangible Assets |  | $ | 324.6 |  |  | $ | (90.9 | ) |  | $ | 233.7 |  |  |  |  |

14

Table of Contents

|  | As of May 2, 2020 |
(Dollars in Millions) |  | Gross |  |  | Accumulated Amortization |  |  | Net |  |  | Wtd. Avg. Remaining Amortization Periods (Years) |
Definite-lived Intangible Assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Customer Relationships and Agreements |  | $ | 243.5 |  |  | $ | (40.8 | ) |  | $ | 202.7 |  |  |  | 16.5 |
Trade Names, Patents and Technology Licenses |  |  | 75.3 |  |  |  | (35.0 | ) |  |  | 40.3 |  |  |  | 7.8 |
Total Definite-lived Intangible Assets |  |  | 318.8 |  |  |  | (75.8 | ) |  |  | 243.0 |  |  |  |  |
Indefinite-lived Intangible Assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Trade Names, Patents and Technology Licenses |  |  | 1.8 |  |  |  | — |  |  |  | 1.8 |  |  |  |  |
Total Indefinite-lived Intangible Assets |  |  | 1.8 |  |  |  | — |  |  |  | 1.8 |  |  |  |  |
Total Other Intangible Assets |  | $ | 320.6 |  |  | $ | (75.8 | ) |  | $ | 244.8 |  |  |  |  |

Based on the current amount of intangible assets subject to amortization, the estimated aggregate amortization expense for each of the five succeeding fiscal years and thereafter is as follows:

(Dollars in Millions) |  |  |  |
Fiscal Year: |  |  |  |
Remainder of 2021 |  | $ | 4.8 |
2022 |  |  | 19.2 |
2023 |  |  | 19.1 |
2024 |  |  | 18.7 |
2025 |  |  | 18.2 |
Thereafter |  |  | 151.9 |
Total |  | $ | 231.9 |

Note 7.Debt

A summary of debt is shown below:

(Dollars in Millions) |  | January 30, 2021 |  |  | May 2, 2020 |
Revolving Credit Facility |  | $ | 9.7 |  |  | $ | 108.5 |
Term Loan |  |  | 221.9 |  |  |  | 231.2 |
Other Debt |  |  | 14.7 |  |  |  | 14.6 |
Unamortized Debt Issuance Costs |  |  | (1.7 | ) |  |  | (2.2 | )
Total Debt |  |  | 244.6 |  |  |  | 352.1 |
Less: Current Maturities |  |  | (15.4 | ) |  |  | (15.3 | )
Total Long-term Debt |  | $ | 229.2 |  |  | $ | 336.8 |

15

Table of Contents

Revolving Credit Facility/Term Loan

The Company is a party to an Amended and Restated Credit Agreement (“Credit Agreement”) with Bank of America, N.A., as Administrative Agent, and Wells Fargo Bank, N.A. The Credit Agreement terminates in September 2023 and consists of a senior unsecured revolving credit facility (“Revolving Credit Facility”) of $200.0 million and a senior unsecured term loan (“Term Loan”) of $250.0 million. In addition, the Company has an option to increase the size of the Revolving Credit Facility and Term Loan by up to an additional $200.0 million, subject to customary conditions and approval of the lenders providing new commitments. The Credit Agreement is guaranteed by the Company’s wholly-owned U.S. subsidiaries. For the Term Loan, the Company is required to make quarterly principal payments of 1.25% of the original Term Loan ($3.1 million) through maturity, with the remaining balance due on September 12, 2023.

Outstanding borrowings under the Credit Agreement bear interest at variable rates based on the type of borrowing and the Company’s debt to EBITDA financial ratio, as defined in the Credit Agreement. The weighted-average interest rate on outstanding borrowings under the Credit Agreement was 1.63% at January 30, 2021. The Credit Agreement contains customary representations and warranties, financial covenants, restrictive covenants and events of default. As of January 30, 2021, the Company was in compliance with all the covenants in the Credit Agreement.

Other Debt

One of the Company’s European subsidiaries has debt that consists of 14 notes with maturities ranging from 2021 to 2031. The weighted-average interest rate on this debt was approximately 1.47% at January 30, 2021 and $2.9 million of the debt was classified as short-term.

Note 8.Shareholders’ Equity

Dividends

The Company paid dividends totaling $4.1 million and $4.0 million in the three months ended January 30, 2021 and February 1, 2020, respectively. The Company paid dividends totaling $13.2 million and $12.2 million in the nine months ended January 30, 2021 and February 1, 2020, respectively. Dividends paid in the nine months ended January 30, 2021 include $0.9 million of dividends on restricted stock that vested during the period.

Accumulated Other Comprehensive Income (Loss)

Comprehensive income (loss) is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources. A summary of changes in accumulated other comprehensive income (loss), net of tax is shown below:

|  | Three Months Ended |  |  | Nine Months Ended |
|  | January 30, 2021 |  |  | February 1, 2020 |  |  | January 30, 2021 |  |  | February 1, 2020 |
(Dollars in Millions) |  | (13 Weeks) |  |  | (14 Weeks) |  |  | (39 Weeks) |  |  | (40 Weeks) |
Currency Translation Adjustments: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance at Beginning of Period |  | $ | (4.2 | ) |  | $ | (18.0 | ) |  | $ | (25.9 | ) |  | $ | (13.6 | )
Other Comprehensive Income (Loss) Recognized During the Period, Net of Tax Expense of $0.3 million; $—; $0.6 million; $— |  |  | 18.2 |  |  |  | 1.6 |  |  |  | 39.9 |  |  |  | (2.8 | )
Balance at End of Period |  |  | 14.0 |  |  |  | (16.4 | ) |  |  | 14.0 |  |  |  | (16.4 | )
Derivative Instruments: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance at Beginning of Period |  |  | (3.7 | ) |  |  | — |  |  |  | (1.0 | ) |  |  | — |
Other Comprehensive Loss Recognized During the Period, Net of Tax Benefit of $0.6 million; $—; $1.5 million; $— |  |  | (2.1 | ) |  |  | — |  |  |  | (4.8 | ) |  |  | — |
Balance at End of Period |  |  | (5.8 | ) |  |  | — |  |  |  | (5.8 | ) |  |  | — |
Accumulated Other Comprehensive Income (Loss), End of Period |  | $ | 8.2 |  |  | $ | (16.4 | ) |  | $ | 8.2 |  |  | $ | (16.4 | )

16

Table of Contents

Stock-based Compensation

The Company has granted stock options, performance-based restricted stock (“PSAs”), performance units (“PUs”), restricted stock units (“RSUs”) and stock awards to employees and non-employee directors under the Methode Electronics, Inc. 2014 Omnibus Incentive Plan (“2014 Plan”), the Methode Electronics, Inc. 2010 Stock Plan (“2010 Plan”), the Methode Electronics, Inc. 2007 Stock Plan (“2007 Plan”) and the Methode Electronics, Inc. 2004 Stock Plan (“2004 Plan”). The Company can no longer make grants under the 2010 Plan, 2007 Plan and 2004 Plan. The number of shares of common stock originally authorized under the 2014 Plan is 3,000,000. As of January 30, 2021, there were 196,288 shares available for award under the 2014 Plan.

The Company accounts for stock-based compensation under the fair-value method. Accordingly, equity-classified stock-based compensation cost is measured at the grant date, based on the fair value of the award, and is recognized as compensation cost over the requisite service period. The requisite service period generally matches the stated vesting period of the award but may be shorter if the employee is retirement-eligible and, under the award’s terms, may fully vest upon retirement from the Company. The Company recognizes compensation cost for awards that have graded vesting features under the graded vesting method, which considers each separately vesting tranche as though they were, in substance, multiple awards.

Performance-based Restricted Stock (“PSAs”) and Performance Units (“PUs”)

In the second quarter of fiscal 2021, the Company granted 917,000 PSAs to executive officers and certain non-executives which will be earned based on the achievement of an earnings before net interest, taxes, fixed asset depreciation and intangible asset amortization (“EBITDA”) measure for fiscal 2025. The PSAs will vest ranging from 0% (for performance below threshold) to 100% (target performance) based on the achievement of the EBITDA performance measure and continued employment. In addition, if the target performance is exceeded, an additional 458,500 PUs can be earned that will be settled in cash. At the discretion of the Compensation Committee, the PUs may be settled in shares of common stock.

The fair value of the PSAs was based on the closing stock price on the date of grant and earn dividend equivalents during the vesting period, which are forfeitable if the PSAs do not vest. Compensation expense for PSAs are recognized when it is probable the minimum threshold performance criteria will be achieved. Compensation expense for the PUs are recognized when it is probable that the target performance criteria will be achieved. The Company assesses the probability of vesting at each balance sheet date and adjusts compensation costs based on the probability assessment. The cash-settled PUs represent a non-equity unit with a conversion value equal to the fair market value of a share of the Company’s common stock on the vesting date. The PUs are classified as liability awards due to the cash settlement feature and are re-measured at each balance sheet date. In accordance with ASC 718, based on projections of the Company’s current business portfolio, compensation expense has not been recognized for the PSAs or PUs in the three and nine months ended January 30, 2021, as the performance conditions are not probable of being met.

Restricted Stock Units (“RSUs”)

RSUs granted under the 2014 Plan vest over a pre-determined period of time, up to five years. In the second quarter of fiscal 2021, the Company granted 938,300 RSUs to executive officers and certain non-executives. The fair value of the RSUs was based on the closing stock price on the date of grant and earn dividend equivalents during the vesting periods, which are forfeitable if the RSUs don’t vest.

The following table summarizes RSU activity under the 2014 Plan:

|  | RSU Shares |  |  | Wtd. Avg. Grant Date Fair Value |
Non-vested at May 2, 2020 |  |  | 3,100 |  |  | $ | 41.20 |
Awarded |  |  | 938,300 |  |  | $ | 28.30 |
Vested |  |  | — |  |  | $ | — |
Forfeited |  |  | — |  |  | $ | — |
Non-vested at January 30, 2021 |  |  | 941,400 |  |  | $ | 28.34 |

Under the various stock plans, common stock underlying vested RSUs held by certain executives will not be delivered until termination of employment or a change of control of the Company. As of January 30, 2021, common stock to be delivered to these executives totaled 577,055 shares.

17

Table of Contents

Director Awards

In the nine months ended January 30, 2021 and February 1, 2020, the Company granted 33,000 shares and 30,000 shares, respectively, of common stock to its non-employee directors under the 2014 Plan. The shares vested immediately upon grant. The fair value was determined based on the closing price of the Company’s stock on the date of grant.

Stock Options

The following table summarizes combined stock option activity under the 2010 Plan and 2007 Plan:

|  | Shares |  |  | Wtd. Avg. Exercise Price |
Outstanding and Exercisable at May 2, 2020 |  |  | 106,668 |  |  | $ | 35.76 |
Exercised |  |  | (5,000 | ) |  | $ | 10.55 |
Forfeited |  |  | (1,668 | ) |  | $ | 37.01 |
Outstanding and Exercisable at January 30, 2021 |  |  | 100,000 |  |  | $ | 37.01 |

Stock-based Compensation Expense

All stock-based awards to employees and non-employee directors are recognized in selling and administrative expenses on the condensed consolidated statements of income.

The following table summarizes the stock-based compensation expense related to the equity awards:

|  | Three Months Ended |  |  | Nine Months Ended |
|  | January 30, 2021 |  |  | February 1, 2020 |  |  | January 30, 2021 |  |  | February 1, 2020 |
(Dollars in Millions) |  | (13 Weeks) |  |  | (14 Weeks) |  |  | (39 Weeks) |  |  | (40 Weeks) |
PSAs |  | $ | — |  |  | $ | 1.3 |  |  | $ | — |  |  | $ | 3.6 |
RSUs |  |  | 2.4 |  |  |  | 0.3 |  |  |  | 3.4 |  |  |  | 1.1 |
Director Awards |  |  | — |  |  |  | — |  |  |  | 0.9 |  |  |  | 0.9 |
Total Stock-based Compensation Expense |  | $ | 2.4 |  |  | $ | 1.6 |  |  | $ | 4.3 |  |  | $ | 5.6 |

Note 9. Income per Share

Basic income per share is calculated by dividing net income by the weighted average number of common shares outstanding for the applicable period, but excludes any contingently issued shares where the contingency has not been resolved. The weighted average number of common shares used in the diluted income per share calculation is determined using the treasury stock method which includes the effect of all potential dilutive common shares outstanding during the period.

18

Table of Contents

The following table sets forth the computation of basic and diluted income per share:

|  | Three Months Ended |  |  | Nine Months Ended |
|  | January 30, 2021 |  |  | February 1, 2020 |  |  | January 30, 2021 |  |  | February 1, 2020 |
|  | (13 Weeks) |  |  | (14 Weeks) |  |  | (39 Weeks) |  |  | (40 Weeks) |
Numerator: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net Income (in millions) |  | $ | 31.9 |  |  | $ | 41.2 |  |  | $ | 91.2 |  |  | $ | 93.3 |
Denominator: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Denominator for Basic Income per Share-Weighted Average Shares Outstanding and Vested/Unissued RSUs |  |  | 38,106,793 |  |  |  | 37,587,742 |  |  |  | 38,016,711 |  |  |  | 37,570,423 |
Dilutive Potential Common Shares-Employee Stock Options, PSAs and RSUs |  |  | 293,303 |  |  |  | 166,229 |  |  |  | 211,974 |  |  |  | 150,093 |
Denominator for Diluted Income per Share |  |  | 38,400,096 |  |  |  | 37,753,971 |  |  |  | 38,228,685 |  |  |  | 37,720,516 |
Basic and Diluted Income per Share: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic Income per Share |  | $ | 0.84 |  |  | $ | 1.10 |  |  | $ | 2.40 |  |  | $ | 2.48 |
Diluted Income per Share |  | $ | 0.83 |  |  | $ | 1.09 |  |  | $ | 2.39 |  |  | $ | 2.47 |
Number of Anti-dilutive Potentially Issuable Shares Excluded from Diluted Common Shares Outstanding |  |  | 917,000 |  |  |  | 646,075 |  |  |  | 678,556 |  |  |  | 721,604 |

Note 10. Segment Information

An operating segment is defined as a component of an enterprise that engages in business activities from which it may earn revenues and incur expenses, and about which separate financial information is regularly evaluated by the Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources. The CODM is the Company’s President and Chief Executive Officer (“CEO”). The Company has four reporting segments as described below.

The Automotive segment supplies electronic and electro-mechanical devices and related products to automobile OEMs, either directly or through their tiered suppliers. Products include integrated center consoles, hidden switches, ergonomic switches, transmission lead-frames, LED-based lighting and sensors, which incorporate magneto-elastic sensing and other technologies that monitor the operation or status of a component or system.

The Industrial segment manufactures external lighting solutions, industrial safety radio remote controls, braided flexible cables, current-carrying laminated busbars and devices, custom power-product assemblies, such as our PowerRail® solution, high-current low-voltage flexible power cabling systems and powder-coated busbars that are used in various markets and applications, including aerospace, computers, industrial, power conversion, military, telecommunications and transportation.

The Interface segment provides a variety of copper and fiber-optic interface and interface solutions for the appliance, commercial food service, construction, consumer, material handling, point-of-sale and telecommunications markets. Solutions include copper transceivers and solid-state field-effect consumer touch panels.

The Medical segment is made up of the Company's medical device business, Dabir Surfaces, with its surface support technology aimed at pressure injury prevention. Methode has developed the technology for use by patients who are immobilized or otherwise at risk for pressure injuries, including patients undergoing long-duration surgical procedures.

19

Table of Contents

The tables below present information about the Company's reportable segments:

|  | Three Months Ended January 30, 2021 (13 Weeks) |
(Dollars in Millions) |  | Automotive |  |  | Industrial |  |  | Interface |  |  | Medical |  |  | Eliminations /Corporate |  |  | Consolidated |
Net Sales |  | $ | 211.7 |  |  | $ | 68.3 |  |  | $ | 17.6 |  |  | $ | 0.7 |  |  | $ | (3.0 | ) |  | $ | 295.3 |
Transfers between Segments |  |  | (1.2 | ) |  |  | (1.8 | ) |  |  | — |  |  |  | — |  |  |  | 3.0 |  |  |  | — |
Net Sales to Unaffiliated Customers |  | $ | 210.5 |  |  | $ | 66.5 |  |  | $ | 17.6 |  |  | $ | 0.7 |  |  | $ | — |  |  | $ | 295.3 |
Income (Loss) from Operations |  | $ | 29.6 |  |  | $ | 16.9 |  |  | $ | 3.2 |  |  | $ | (1.0 | ) |  | $ | (13.3 | ) |  | $ | 35.4 |
Interest Expense, Net |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1.3 |
Other Income, Net |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (2.4 | )
Income before Income Taxes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 36.5 |

|  | Three Months Ended February 1, 2020 (14 Weeks) |
(Dollars in Millions) |  | Automotive |  |  | Industrial |  |  | Interface |  |  | Medical |  |  | Eliminations /Corporate |  |  | Consolidated |
Net Sales |  | $ | 211.5 |  |  | $ | 60.8 |  |  | $ | 14.9 |  |  | $ | 0.6 |  |  | $ | (1.9 | ) |  | $ | 285.9 |
Transfers between Segments |  |  | (1.2 | ) |  |  | (0.7 | ) |  |  | — |  |  |  | — |  |  |  | 1.9 |  |  |  | — |
Net Sales to Unaffiliated Customers |  | $ | 210.3 |  |  | $ | 60.1 |  |  | $ | 14.9 |  |  | $ | 0.6 |  |  | $ | — |  |  | $ | 285.9 |
Income (Loss) from Operations |  | $ | 39.2 |  |  | $ | 13.2 |  |  | $ | 0.7 |  |  | $ | (1.6 | ) |  | $ | (10.0 | ) |  | $ | 41.5 |
Interest Expense, Net |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2.4 |
Other Income, Net |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (4.9 | )
Income before Income Taxes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 44.0 |

|  | Nine Months Ended January 30, 2021 (39 Weeks) |
(Dollars in Millions) |  | Automotive |  |  | Industrial |  |  | Interface |  |  | Medical |  |  | Eliminations /Corporate |  |  | Consolidated |
Net Sales |  | $ | 555.0 |  |  | $ | 190.2 |  |  | $ | 47.4 |  |  | $ | 1.9 |  |  | $ | (7.5 | ) |  | $ | 787.0 |
Transfers between Segments |  |  | (3.7 | ) |  |  | (3.8 | ) |  |  | — |  |  |  | — |  |  |  | 7.5 |  |  |  | — |
Net Sales to Unaffiliated Customers |  | $ | 551.3 |  |  | $ | 186.4 |  |  | $ | 47.4 |  |  | $ | 1.9 |  |  | $ | — |  |  | $ | 787.0 |
Income (Loss) from Operations |  | $ | 83.7 |  |  | $ | 40.0 |  |  | $ | 7.4 |  |  | $ | (4.1 | ) |  | $ | (32.8 | ) |  | $ | 94.2 |
Interest Expense, Net |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 4.3 |
Other Income, Net |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (8.4 | )
Income before Income Taxes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 98.3 |

|  | Nine Months Ended February 1, 2020 (40 Weeks) |
(Dollars in Millions) |  | Automotive |  |  | Industrial |  |  | Interface |  |  | Medical |  |  | Eliminations /Corporate |  |  | Consolidated |
Net Sales |  | $ | 580.3 |  |  | $ | 197.8 |  |  | $ | 39.8 |  |  | $ | 1.2 |  |  | $ | (5.8 | ) |  | $ | 813.3 |
Transfers between Segments |  |  | (3.7 | ) |  |  | (2.0 | ) |  |  | (0.1 | ) |  |  | — |  |  |  | 5.8 |  |  |  | — |
Net Sales to Unaffiliated Customers |  | $ | 576.6 |  |  | $ | 195.8 |  |  | $ | 39.7 |  |  | $ | 1.2 |  |  | $ | — |  |  | $ | 813.3 |
Income (Loss) from Operations |  | $ | 101.2 |  |  | $ | 44.8 |  |  | $ | 0.7 |  |  | $ | (4.9 | ) |  | $ | (31.0 | ) |  | $ | 110.8 |
Interest Expense, Net |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 8.0 |
Other Income, Net |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (5.8 | )
Income before Income Taxes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 108.6 |

20

Table of Contents

(Dollars in Millions) |  | January 30, 2021 |  |  | May 2, 2020 |
Identifiable Assets: |  |  |  |  |  |  |  |
Automotive |  | $ | 797.1 |  |  | $ | 670.9 |
Industrial |  |  | 452.6 |  |  |  | 421.8 |
Interface |  |  | 67.3 |  |  |  | 71.0 |
Medical |  |  | 7.4 |  |  |  | 8.8 |
Eliminations/Corporate |  |  | 120.1 |  |  |  | 198.1 |
Total Identifiable Assets |  | $ | 1,444.5 |  |  | $ | 1,370.6 |

Note 11. Contingencies

Certain litigation arising in the normal course of business is pending against us. The Company is, from time-to-time, subject to various legal actions and claims incidental to our business, including those arising out of alleged defects, breach of contracts, employment-related matters, environmental matters and intellectual property matters. The Company considers insurance coverage and third-party indemnification when determining required accruals for pending litigation and claims. Although the outcome of potential legal actions and claims cannot be determined, it is the Company's opinion, based on the information available, that it has adequate reserves for these liabilities.

Hetronic Germany-GmbH Matters

For several years, Hetronic Germany-GmbH and Hydronic-Steuersysteme-GmbH (the “Fuchs companies”) served as our distributors for Germany, Austria and other central and eastern European countries pursuant to their respective intellectual property licenses and distribution and assembly agreements. The Company became aware that the Fuchs companies and their managing director, Albert Fuchs, had materially violated those agreements. As a result, the Company terminated all of its agreements with the Fuchs companies. On June 20, 2014, the Company filed a lawsuit against the Fuchs companies in the Federal District Court for the Western District of Oklahoma alleging material breaches of the distribution and assembly agreements and seeking damages, as well as various forms of injunctive relief. The defendants filed counterclaims alleging breach of contract, interference with business relations and business slander. On April 2, 2015, the Company amended its complaint against the Fuchs companies to add additional unfair competition and Lanham Act claims and to add additional affiliated parties. A trial with respect to the matter began in February 2020. During the trial, the defendants dismissed their one remaining counterclaim with prejudice. On March 2, 2020, the jury returned a verdict in favor of the Company. The verdict included approximately $102 million in compensatory damages and $11 million in punitive damages. On April 22, 2020, the Court entered a permanent injunction barring defendants from selling infringing products and ordering them to return Hetronic’s confidential information. Defendants appealed entry of the permanent injunction. On May 29, 2020, the Court held defendants in contempt for violating the permanent injunction and entered the final judgment. Defendants appealed entry of the final monetary judgment as well. The appeal of the permanent injunction and the appeal of the final judgment have been consolidated into a single appeal. That appeal is fully briefed and has been set for argument on March 8, 2021. The Court will issue a decision sometime thereafter. The Company is working with counsel to collect on the judgment though there are challenges in Europe in doing so while the appeal is pending. Like any judgment, particularly any judgment involving defendants outside of the United States, there is no guarantee that the Company will be able to collect the judgment.

21

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Cautionary Statement

Certain statements in this report are forward-looking statements that are subject to certain risks and uncertainties. We undertake no duty to update any such forward-looking statements to conform to actual results or changes in our expectations. Our business is highly dependent upon two large automotive customers and specific makes and models of vehicles. Our results will be subject to many of the same risks that apply to the automotive, appliance, commercial vehicle, computer and communications industries, such as general economic conditions, interest rate fluctuations, consumer spending patterns and technological changes. Other factors which may result in materially different results for future periods include the following risk factors. Additional risks and uncertainties not presently known or that our management currently believe to be insignificant may also adversely affect our financial condition or results of operations. These risk factors should be considered in connection with evaluating the forward-looking statements contained in this report because these factors could cause our actual results and condition to differ materially from those projected in forward-looking statements. The forward-looking statements in this report are subject to the safe harbor protection provided under the securities laws and are made as of the date of this report. Among the factors that could cause actual results to differ materially from past results and future plans and projected future results are the following:

| • | Impact from pandemics, such as the COVID-19 pandemic;

| • | Dependence on our supply chain, including semiconductor and resin suppliers;

| • | Dependence on the automotive, appliance, commercial vehicle, computer and communications industries;

| • | Dependence on a small number of large customers, including two large automotive customers;

| • | Recognition of goodwill and long-lived asset impairment charges;

| • | Timing and magnitude of costs associated with restructuring activities;

| • | International trade disputes resulting in tariffs and our ability to mitigate tariffs;

| • | Timing, quality and cost of new program launches;

| • | Ability to withstand price pressure, including pricing reductions;

| • | Failure to attract and retain qualified personnel;

| • | Ability to successfully market and sell Dabir Surfaces products;

| • | Currency fluctuations;

| • | Customary risks related to conducting global operations;

| • | Costs associated with environmental, health and safety regulations;

| • | Ability to withstand business interruptions;

| • | Ability to successfully benefit from acquisitions and divestitures;

| • | Investment in programs prior to the recognition of revenue;

| • | Dependence on the availability and price of materials;

| • | Judgments related to accounting for tax positions;

| • | Income tax rate fluctuations;

| • | Adjustments to compensation expense for performance-based awards;

| • | Ability to keep pace with rapid technological changes;

| • | Breaches to our information technology systems;

| • | Ability to avoid design or manufacturing defects;

| • | Ability to compete effectively;

| • | Ability to protect our intellectual property;

| • | Success of recent acquisitions and/or our ability to implement and profit from new applications of the acquired technology;

| • | Ability to manage our debt levels and any restrictions thereunder; and

| • | Impact to interest expense from the replacement or modification of LIBOR.

Any such forward-looking statements are not guarantees of future performance and actual results, developments and business decisions may differ materially from those foreseen in such forward-looking statements. These forward-looking statements speak only

22

Table of Contents

as of the date of the report, press release, statement, document, webcast or oral discussion in which they are made. We do not intend to update any forward-looking statements, all of which are expressly qualified by the foregoing. See Part I — Item 1A, Risk Factors of our Form 10-K for the fiscal year ended May 2, 2020 and Part II - Item 1A, Risk Factors of this Form 10-Q for further discussions regarding some of the reasons that actual results may be materially different from those we anticipate.

Overview

We are a global developer of custom engineered and application specific products and solutions with manufacturing, design and testing facilities in Belgium, Canada, China, Egypt, Germany, India, Italy, Lebanon, Malta, Mexico, the Netherlands, Singapore, Switzerland, the United Kingdom and the United States. Our primary manufacturing facilities are located in Dongguan and Shanghai, China; Cairo, Egypt; Mriehel, Malta; and Monterrey, Mexico. We design, manufacture and market devices employing electrical, electronic, LED lighting, sensors and radio remote control technologies. Our business is managed, and our financial results are reported, on a segment basis, with those segments being Automotive, Industrial, Interface and Medical.

Our components are found in the primary end-markets of the aerospace, appliance, automotive, commercial vehicle, construction, consumer and industrial equipment, communications (including information processing and storage, networking equipment and wireless and terrestrial voice/data systems), medical, rail and other transportation industries.

Impact of COVID-19

The COVID-19 global pandemic has negatively affected the global economy, disrupted global supply chains, and created significant volatility and disruptions to capital and credit markets in the global financial markets. We began to see the impacts of COVID-19 at the beginning of our fourth quarter of fiscal 2020 at our China manufacturing facilities, which were initially closed after the Chinese New Year. Our manufacturing facilities in China resumed operations later in the fourth quarter of fiscal 2020, but at lower capacity utilization. However, the major impact to our business from the COVID-19 pandemic began in mid-March 2020, as our operations in North America and Europe were adversely impacted by many of our customers suspending their manufacturing operations due to the COVID-19 pandemic. In the first quarter of fiscal 2021, our operations in North America and Europe gradually resumed operations, however production levels were still significantly reduced, resulting in lower capacity utilization, thus impacting our results of operations during the first quarter of fiscal 2021. In the second quarter of fiscal 2021, production levels in North America and Europe returned to pre-COVID levels as a result of increased demand from customers and continued into our third quarter of fiscal 2021. However, towards the end of our third quarter of fiscal 2021, many automotive companies announced a slowdown in their production schedules due to a worldwide semiconductor supply shortage. The semiconductor supply shortage is impacting our supply chain and our ability to meet demand at some of our non-automotive customers. We expect this semiconductor shortage will likely have a short-term impact on our operating results and financial condition in the fourth quarter of fiscal 2021, and possibly into fiscal 2022.

In response to the COVID-19 pandemic and business disruption, in March 2020, we implemented certain measures to manage costs, preserve liquidity and enhance employee safety. These measures included the following:

| • | Reduction of payroll costs through a combination of temporary salary reductions, four-day work weeks and furloughs. In the second quarter of fiscal 2021, we ceased the salary reductions and resumed five-day work weeks;

| • | Elimination of most business travel and restriction of visitors to our facilities;

| • | Enhanced cleaning and disinfection procedures at our facilities, temperature checks for our workers before they enter our manufacturing facilities, promotion of social distancing at our facilities and requirements for employees to work from home where possible;

| • | Reduction of non-program related capital expenditures;

| • | Deferral of discretionary spending; and

| • | The March 2020 draw-down of $100.0 million under our revolving credit facility, which was repaid in full in the third quarter of fiscal 2021. The initial draw-down was as a precautionary measure in order to increase our cash position and preserve financial flexibility.

23

Table of Contents

In addition, we initiated certain restructuring actions in the nine months ended January 30, 2021 to rationalize our operations, lower our costs and improve financial performance and long-term cash flow generation‎. These actions included plant consolidations and workforce reductions in the Automotive, Industrial and Interface segments. In the three months and nine months ended January 30, 2021, we recognized $0.7 million and $8.3 million of restructuring costs, respectively. We currently expect to incur additional restructuring costs of approximately $0.2 million during the current ‎fiscal year related to the initiated restructuring programs and we may take additional restructuring actions in future periods based upon market conditions and industry trends.

The extent of the impact of the COVID-19 pandemic on our business, financial results and liquidity will depend largely on future developments, including the duration of the spread of the COVID-19 outbreak within the U.S. and globally, the impact on capital and financial markets and the related impact on our customers, especially in the automotive and commercial vehicle markets. These future developments are outside of our control, are highly uncertain and cannot be predicted. If the impact is further prolonged, then it can further increase the difficulty of planning for operations and may require us to take further actions as it relates to costs and liquidity. These and other potential impacts of the COVID-19 pandemic, including the resulting global semiconductor chip shortage, may adversely impact our results for the remainder of fiscal 2021 and into fiscal 2022, and that impact could be material. We continue to actively monitor the ongoing potential impacts of COVID-19 and will seek to mitigate and minimize its impact on our business.

Financial Reporting Periods

We maintain our financial records on the basis of a 52- or 53-week fiscal year ending on the Saturday closest to April 30. Fiscal 2021 is a 52-week year and fiscal 2020 was a 53-week year. For the three months ended January 30, 2021, our accounting period included 13 weeks compared to 14 weeks for the three months ended February 1, 2020. For the nine months ended January 30, 2021, our accounting period included 39 weeks compared to 40 weeks for the nine months ended February 1, 2020. The following discussions of comparative results among periods should be reviewed in this context.

24

Table of Contents

Results of Operations for the Three Months Ended January 30, 2021 compared to the Three Months Ended February 1, 2020

Consolidated Results

Below is a table summarizing results for the three months ended:

|  | January 30, 2021 |  |  | February 1, 2020 |  |  |  |  |  |  |  |  |
(Dollars in Millions) |  | (13 Weeks) |  |  | (14 Weeks) |  |  | Net Change ($) |  |  | Net Change (%) |
Net Sales |  | $ | 295.3 |  |  | $ | 285.9 |  |  | $ | 9.4 |  |  |  | 3.3 | %
Cost of Products Sold |  |  | 222.7 |  |  |  | 206.6 |  |  |  | 16.1 |  |  |  | 7.8 | %
Gross Profit |  |  | 72.6 |  |  |  | 79.3 |  |  |  | (6.7 | ) |  |  | (8.4 | )%
Selling and Administrative Expenses |  |  | 32.4 |  |  |  | 33.0 |  |  |  | (0.6 | ) |  |  | (1.8 | )%
Amortization of Intangibles |  |  | 4.8 |  |  |  | 4.8 |  |  |  | — |  |  |  | — |
Interest Expense, Net |  |  | 1.3 |  |  |  | 2.4 |  |  |  | (1.1 | ) |  |  | (45.8 | )%
Other Income, Net |  |  | (2.4 | ) |  |  | (4.9 | ) |  |  | 2.5 |  |  |  | (51.0 | )%
Income Tax Expense |  |  | 4.6 |  |  |  | 2.8 |  |  |  | 1.8 |  |  |  | 64.3 | %
Net Income |  | $ | 31.9 |  |  | $ | 41.2 |  |  | $ | (9.3 | ) |  |  | (22.6 | )%
|  | January 30, 2021 |  |  | February 1, 2020 |  |  |  |  |  |  |  |  |
Percent of sales: |  | (13 Weeks) |  |  | (14 Weeks) |  |  |  |  |  |  |  |  |
Net Sales |  |  | 100.0 | % |  |  | 100.0 | % |  |  |  |  |  |  |  |
Cost of Products Sold |  |  | 75.4 | % |  |  | 72.3 | % |  |  |  |  |  |  |  |
Gross Profit |  |  | 24.6 | % |  |  | 27.7 | % |  |  |  |  |  |  |  |
Selling and Administrative Expenses |  |  | 11.0 | % |  |  | 11.5 | % |  |  |  |  |  |  |  |
Amortization of Intangibles |  |  | 1.6 | % |  |  | 1.7 | % |  |  |  |  |  |  |  |
Interest Expense, Net |  |  | 0.4 | % |  |  | 0.8 | % |  |  |  |  |  |  |  |
Other Income, Net |  |  | (0.8 | )% |  |  | (1.7 | )% |  |  |  |  |  |  |  |
Income Tax Expense |  |  | 1.6 | % |  |  | 1.0 | % |  |  |  |  |  |  |  |
Net Income |  |  | 10.8 | % |  |  | 14.4 | % |  |  |  |  |  |  |  |

Net Sales. Net sales increased $9.4 million, or 3.3%, to $295.3 million in the three months ended January 30, 2021, compared to $285.9 million in the three months ended February 1, 2020. The impact of foreign currency translation increased net sales by $9.7 million, primarily due to the strengthening of the euro and Chinese renminbi, relative to the U.S. dollar. Excluding the impact of foreign currency translation, net sales were comparable in both periods. See results by segment for additional details.

Cost of Products Sold. Cost of products sold increased $16.1 million, or 7.8%, to $222.7 million (75.4% of sales) in the three months ended January 30, 2021, compared to $206.6 million (72.3% of sales) in the three months ended February 1, 2020. The impact of foreign currency translation increased cost of products sold by $6.9 million. Excluding the impact of foreign currency translation, cost of products sold increased by $9.2 million. The increase was primarily due to premium freight and factory inefficiencies resulting from supply chain disruptions due to the COVID-19 pandemic and to a lesser extent tariff expense and product sales mix.

Gross Profit. Gross profit decreased $6.7 million, or 8.4%, to $72.6 million (24.6% of sales) in the three months ended January 30, 2021, compared to $79.3 million (27.7% of sales) in the three months ended February 1, 2020. The impact of foreign currency translation increased gross profit by $2.8 million. Excluding the impact of foreign currency translation, gross profit decreased by $9.5 million. The decrease in gross profit margins was primarily due to premium freight and factory inefficiencies resulting from supply chain disruptions due to the COVID-19 pandemic and to a lesser extent tariff expense and product sales mix.

Selling and Administrative Expenses. Selling and administrative expenses decreased $0.6 million, or 1.8%, to $32.4 million (11.0% of sales) in the three months ended January 30, 2021, compared to $33.0 million (11.5% of sales) in the three months ended February 1, 2020. The impact of foreign currency translation increased selling and administrative expenses by $0.7 million. Excluding the impact of foreign currency translation, selling and administrative expenses decreased by $1.3 million. The decrease was primarily due to lower compensation expense, travel expense and restructuring costs, partially offset by higher stock-based compensation

25

Table of Contents

expense. The decrease in compensation expense was primarily related to the benefit of restructuring actions taken in the first quarter of fiscal 2021. In the three months ended January 30, 2021, we recognized $0.3 million of restructuring costs related to actions taken to reduce overall costs and improve operational profitability, compared to $0.7 million of restructuring costs recognized in the three months ended February 1, 2020.

Amortization of Intangibles. Amortization of intangibles was unchanged at $4.8 million in both the three months ended January 30, 2021 and February 1, 2020.

Interest Expense, Net. Interest expense, net was $1.3 million in the three months ended January 30, 2021, compared to $2.4 million in the three months ended February 1, 2020. The decrease was due to a lower effective interest rate on outstanding borrowings, partially offset by higher average borrowings. Average borrowings were higher due to the precautionary $100.0 million draw-down in March 2020, which was fully repaid in the three months ended January 30, 2021.

Other Income, Net. Other income, net was $2.4 million in the three months ended January 30, 2021, compared to $4.9 million in the three months ended February 1, 2020. In the three months ended January 30, 2021, we received $2.7 million of government assistance at certain of our international locations with respect to the COVID-19 pandemic. The three months ended February 1, 2020 includes $5.6 million for an international government grant for maintaining certain employment levels during those periods.

Income Tax Expense. Income tax expense was $4.6 million (12.6% effective tax rate) in the three months ended January 30, 2021, compared to $2.8 million (6.4% effective tax rate) in the three months ended February 1, 2020. The effective tax rate in the three months ended January 30, 2021 was lower than the U.S. statutory tax rate primarily due to foreign operations with lower statutory tax rates. The effective tax rate in the three months ended February 1, 2020 was lower than the U.S. statutory tax rate primarily due to beneficial changes related to U.S. Tax Reform and foreign operations with lower statutory rates.

Net Income. Net income decreased $9.3 million, or 22.6%, to $31.9 million in the three months ended January 30, 2021, compared to $41.2 million in the three months ended February 1, 2020. Net income decreased as a result of the reasons described above, partially offset by favorable foreign currency translation of $1.8 million.

Operating Segments

Automotive Segment Results

Below is a table summarizing results for the three months ended:

|  | January 30, 2021 |  |  | February 1, 2020 |  |  |  |  |  |  |  |  |
(Dollars in Millions) |  | (13 Weeks) |  |  | (14 Weeks) |  |  | Net Change ($) |  |  | Net Change (%) |
Net Sales |  | $ | 210.5 |  |  | $ | 210.3 |  |  | $ | 0.2 |  |  |  | 0.1 | %
Gross Profit |  | $ | 44.1 |  |  | $ | 55.0 |  |  | $ | (10.9 | ) |  |  | (19.8 | )%
Income from Operations |  | $ | 29.6 |  |  | $ | 39.2 |  |  | $ | (9.6 | ) |  |  | (24.5 | )%
Percent of sales: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net Sales |  |  | 100.0 | % |  |  | 100.0 | % |  |  |  |  |  |  |  |
Gross Profit |  |  | 21.0 | % |  |  | 26.2 | % |  |  |  |  |  |  |  |
Income from Operations |  |  | 14.1 | % |  |  | 18.6 | % |  |  |  |  |  |  |  |

26

Table of Contents

Net Sales. Automotive segment net sales increased $0.2 million, or 0.1%, to $210.5 million in the three months ended January 30, 2021, compared to $210.3 million in the three months ended February 1, 2020. The impact of foreign currency translation increased net sales by $7.5 million. Excluding the impact of foreign currency translation, net sales decreased by $7.3 million. Net sales in North America decreased $22.6 million, or 17.3%, to $107.7 million in the three months ended January 30, 2021, compared to $130.3 million in the three months ended February 1, 2020. The decrease was primarily due to lower electric vehicle product sales, which shifted from North America to Asia, and lower lighting product sales volumes. Net sales in Europe increased $2.9 million, or 5.1%, to $60.1 million in the three months ended January 30, 2021, compared to $57.2 million in the three months ended February 1, 2020. The stronger euro, relative to the U.S. dollar, increased net sales in Europe by $4.7 million. Excluding the impact of foreign currency translation, Europe net sales decreased $1.8 million primarily due to product mix. Net sales in Asia increased $19.9 million, or 87.3%, to $42.7 million in the three months ended January 30, 2021, compared to $22.8 million in the three months ended February 1, 2020. The stronger Chinese renminbi, relative to the U.S. dollar, increased net sales in Asia by $2.8 million. Excluding foreign currency translation, Asia net sales increased $17.1 million primarily due to higher sales of electric vehicle products which shifted from North America to Asia and higher leadframe sales volumes.

Gross Profit. Automotive segment gross profit decreased $10.9 million, or 19.8%, to $44.1 million in the three months ended January 30, 2021, compared to $55.0 million in the three months ended February 1, 2020. The impact of foreign currency translation increased gross profit by $1.8 million. Excluding the impact of foreign currency translation, gross profit decreased by $12.7 million. Automotive segment gross profit margins decreased to 21.0% in the three months ended January 30, 2021, compared to 26.2% in the three months ended February 1, 2020. The decrease in gross profit margins was primarily due to premium freight and factory inefficiencies resulting from supply chain disruptions due to the COVID-19 pandemic and to a lesser extent tariff expense and product sales mix.

Income from Operations. Automotive segment income from operations decreased $9.6 million, or 24.5%, to $29.6 million in the three months ended January 30, 2021, compared to $39.2 million in the three months ended February 1, 2020. The impact of foreign currency translation increased income from operations by $1.3 million. Excluding the impact of foreign currency translation, income from operations decreased by $10.9 million. The decrease was primarily due to lower gross profit, partially offset by lower selling and administrative expenses. Selling and administrative expenses decreased primarily due to lower compensation expense.

Industrial Segment Results

Below is a table summarizing results for the three months ended:

|  | January 30, 2021 |  |  | February 1, 2020 |  |  |  |  |  |  |  |  |
(Dollars in Millions) |  | (13 Weeks) |  |  | (14 Weeks) |  |  | Net Change ($) |  |  | Net Change (%) |
Net Sales |  | $ | 66.5 |  |  | $ | 60.1 |  |  | $ | 6.4 |  |  |  | 10.6 | %
Gross Profit |  | $ | 24.7 |  |  | $ | 21.9 |  |  | $ | 2.8 |  |  |  | 12.8 | %
Income from Operations |  | $ | 16.9 |  |  | $ | 13.2 |  |  | $ | 3.7 |  |  |  | 28.0 | %
Percent of sales: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net Sales |  |  | 100.0 | % |  |  | 100.0 | % |  |  |  |  |  |  |  |
Gross Profit |  |  | 37.1 | % |  |  | 36.4 | % |  |  |  |  |  |  |  |
Income from Operations |  |  | 25.4 | % |  |  | 22.0 | % |  |  |  |  |  |  |  |

Net Sales. Industrial segment net sales increased $6.4 million, or 10.6%, to $66.5 million in the three months ended January 30, 2021, compared to $60.1 million in the three months ended February 1, 2020. Foreign currency translation increased net sales by $2.2 million. Excluding foreign currency translation, net sales increased by $4.2 million primarily due to higher sales volumes of electric vehicle busbar products and radio remote control devices, partially offset by lower sales from commercial vehicle lighting solutions.

Gross Profit. Industrial segment gross profit increased $2.8 million, or 12.8%, to $24.7 million in the three months ended January 30, 2021, compared to $21.9 million in the three months ended February 1, 2020. Gross profit margins increased to 37.1% in the three months ended January 30, 2021, compared to 36.4% in the three months ended February 1, 2020. The increase in gross profit

27

Table of Contents

margin s was primarily due to higher sales of busbar products and radio remote control devices. This was partially offset by lower gross profit margins from commercial vehicle lighting solutions due to higher operational costs.

Income from Operations. Industrial segment income from operations increased $3.7 million, or 28.0%, to $16.9 million in the three months ended January 30, 2021, compared to $13.2 million in the three months ended February 1, 2020. The increase was primarily due to higher gross profit, lower selling and administrative expenses and favorable foreign currency translation. Selling and administrative expenses decreased due to lower compensation expense. Foreign currency translation increased income from operations by $0.9 million.

Interface Segment Results

Below is a table summarizing results for the three months ended:

|  | January 30, 2021 |  |  | February 1, 2020 |  |  |  |  |  |  |  |  |
(Dollars in Millions) |  | (13 Weeks) |  |  | (14 Weeks) |  |  | Net Change ($) |  |  | Net Change (%) |
Net Sales |  | $ | 17.6 |  |  | $ | 14.9 |  |  | $ | 2.7 |  |  |  | 18.1 | %
Gross Profit |  | $ | 4.0 |  |  | $ | 1.8 |  |  | $ | 2.2 |  |  |  | 122.2 | %
Income from Operations |  | $ | 3.2 |  |  | $ | 0.7 |  |  | $ | 2.5 |  |  |  | 357.1 | %
Percent of sales: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net Sales |  |  | 100.0 | % |  |  | 100.0 | % |  |  |  |  |  |  |  |
Gross Profit |  |  | 22.7 | % |  |  | 12.1 | % |  |  |  |  |  |  |  |
Income from Operations |  |  | 18.2 | % |  |  | 4.7 | % |  |  |  |  |  |  |  |

Net Sales. Interface segment net sales increased $2.7 million, or 18.1%, to $17.6 million in the three months ended January 30, 2021, compared to $14.9 million in the three months ended February 1, 2020. The increase was primarily due to higher sales volumes of appliance products, partially offset by a decrease in legacy data solutions products.

Gross Profit. Interface segment gross profit increased $2.2 million, or 122.2%, to $4.0 million in the three months ended January 30, 2021, compared to $1.8 million in the three months ended February 1, 2020. Gross profit margins increased to 22.7% in the three months ended January 30, 2021, from 12.1% in the three months ended February 1, 2020. The increase was primarily due to higher sales and lower direct labor costs.

Income from Operations. Interface segment income from operations was $3.2 million in the three months ended January 30, 2021, compared to $0.7 million in the three months ended February 1, 2020. The increase was primarily due to higher gross profit and lower selling and administrative expenses. Selling and administrative expenses decreased due to lower compensation expense which benefitted from restructuring actions taken in the first quarter of fiscal 2021.

Medical Segment Results

Below is a table summarizing results for the three months ended:

|  | January 30, 2021 |  |  | February 1, 2020 |  |  |  |  |  |  |  |  |
(Dollars in Millions) |  | (13 Weeks) |  |  | (14 Weeks) |  |  | Net Change ($) |  |  | Net Change (%) |
Net Sales |  | $ | 0.7 |  |  | $ | 0.6 |  |  | $ | 0.1 |  |  |  | 16.7 | %
Gross Profit |  | $ | — |  |  | $ | (0.3 | ) |  | $ | 0.3 |  |  |  | (100.0 | )%
Loss from Operations |  | $ | (1.0 | ) |  | $ | (1.6 | ) |  | $ | 0.6 |  |  |  | (37.5 | )%

Net Sales. The Medical segment had net sales of $0.7 million in the three months ended January 30, 2021, compared to $0.6 million in the three months ended February 1, 2020.

28

Table of Contents

Gross Profit. Medical segment gross profit was breakeven in the three months ended January 30, 2021, compared to a loss of $0.3 million in the three months ended February 1, 2020. The improvement was primarily due to lower cost of products sold and higher net sales.

Loss from Operations. Medical segment loss from operations decreased $0.6 million, to $1.0 million in the three months ended January 30, 2021, compared to $1.6 million in the three months ended February 1, 2020. The improvement was due to lower selling and administrative expenses and higher gross profit.

Results of Operations for the Nine Months Ended January 30, 2021 compared to the Nine Months Ended February 1, 2020

Consolidated Results

Below is a table summarizing results for the nine months ended:

|  | January 30, 2021 |  |  | February 1, 2020 |  |  |  |  |  |  |  |  |
(Dollars in Millions) |  | (39 Weeks) |  |  | (40 Weeks) |  |  | Net Change ($) |  |  | Net Change (%) |
Net Sales |  | $ | 787.0 |  |  | $ | 813.3 |  |  | $ | (26.3 | ) |  |  | (3.2 | )%
Cost of Products Sold |  |  | 588.5 |  |  |  | 589.6 |  |  |  | (1.1 | ) |  |  | (0.2 | )%
Gross Profit |  |  | 198.5 |  |  |  | 223.7 |  |  |  | (25.2 | ) |  |  | (11.3 | )%
Selling and Administrative Expenses |  |  | 89.8 |  |  |  | 98.6 |  |  |  | (8.8 | ) |  |  | (8.9 | )%
Amortization of Intangibles |  |  | 14.5 |  |  |  | 14.3 |  |  |  | 0.2 |  |  |  | 1.4 | %
Interest Expense, Net |  |  | 4.3 |  |  |  | 8.0 |  |  |  | (3.7 | ) |  |  | (46.3 | )%
Other Income, Net |  |  | (8.4 | ) |  |  | (5.8 | ) |  |  | (2.6 | ) |  |  | 44.8 | %
Income Tax Expense |  |  | 7.1 |  |  |  | 15.3 |  |  |  | (8.2 | ) |  |  | (53.6 | )%
Net Income |  | $ | 91.2 |  |  | $ | 93.3 |  |  | $ | (2.1 | ) |  |  | (2.3 | )%
|  | January 30, 2021 |  |  | February 1, 2020 |  |  |  |  |  |  |  |  |
Percent of sales: |  | (39 Weeks) |  |  | (40 Weeks) |  |  |  |  |  |  |  |  |
Net Sales |  |  | 100.0 | % |  |  | 100.0 | % |  |  |  |  |  |  |  |
Cost of Products Sold |  |  | 74.8 | % |  |  | 72.5 | % |  |  |  |  |  |  |  |
Gross Profit |  |  | 25.2 | % |  |  | 27.5 | % |  |  |  |  |  |  |  |
Selling and Administrative Expenses |  |  | 11.4 | % |  |  | 12.1 | % |  |  |  |  |  |  |  |
Amortization of Intangibles |  |  | 1.8 | % |  |  | 1.8 | % |  |  |  |  |  |  |  |
Interest Expense, Net |  |  | 0.5 | % |  |  | 1.0 | % |  |  |  |  |  |  |  |
Other Income, Net |  |  | (1.1 | )% |  |  | (0.7 | )% |  |  |  |  |  |  |  |
Income Tax Expense |  |  | 0.9 | % |  |  | 1.9 | % |  |  |  |  |  |  |  |
Net Income |  |  | 11.6 | % |  |  | 11.5 | % |  |  |  |  |  |  |  |

Net Sales. Net sales decreased $26.3 million, or 3.2%, to $787.0 million in the nine months ended January 30, 2021, compared to $813.3 million in the nine months ended February 1, 2020. The impact of foreign currency translation increased net sales by $15.2 million. Excluding foreign currency translation, net sales decreased $41.5 million as a result of lower sales in the Automotive and Industrial segments, which were negatively impacted by the COVID-19 pandemic, primarily in the first quarter of fiscal 2021. Net sales in the nine months ended February 1, 2020 were negatively impacted by $28.7 million due to the United Auto Workers (“UAW”) labor strike at General Motors (“GM”).

Cost of Products Sold. Cost of products sold decreased $1.1 million, or 0.2%, to $588.5 million (74.8% of sales) in the nine months ended January 30, 2021, compared to $589.6 million (72.5% of sales) in the nine months ended February 1, 2020. The impact of foreign currency translation increased cost of products sold by $11.0 million. Excluding foreign currency translation, cost of products sold decreased $12.1 million. The decrease was primarily due to lower sales volumes and lower labor costs, partially offset by restructuring costs. Labor costs were lower as a result of actions taken in fiscal 2020 in response to the impact from the COVID-19 pandemic on our production volumes. In the nine months ended January 30, 2021, we recognized $5.0 million of restructuring costs

29

Table of Contents

related to actions taken to reduce overall costs and improve operational profitability, compared to $0.6 million of restructuring costs recognized in the nine months ended February 1, 2020.

Gross Profit. Gross profit decreased $25.2 million, or 11.3%, to $198.5 million (25.2% of sales) in the nine months ended January 30, 2021, compared to $223.7 million (27.5% of sales) in the nine months ended February 1, 2020. The impact of foreign currency translation increased gross profit by $4.2 million. Excluding foreign currency translation, gross profit decreased $29.4 million. The decrease in gross profit margins was primarily due to lower sales volumes, product sales mix and restructuring costs, partially offset by lower operational costs.

Selling and Administrative Expenses. Selling and administrative expenses decreased $8.8 million, or 8.9%, to $89.8 million (11.4% of sales) in the nine months ended January 30, 2021, compared to $98.6 million (12.1% of sales) in the nine months ended February 1, 2020. The impact of foreign currency translation increased selling and administrative expenses by $0.7 million. Excluding foreign currency translation, selling and administrative expenses decreased $9.5 million. The decrease was primarily due to lower compensation expense, stock-based compensation expense and travel expense, partially offset by higher restructuring costs. As noted above, we initiated actions which included temporary salary reductions and four-day work weeks (which ended in the second quarter of fiscal 2021) and the elimination of most business travel. In addition, stock-based compensation expense was lower by $1.3 million as our five-year, long-term incentive plan concluded in fiscal 2020 and a new long-term incentive plan was not introduced until September 27, 2020. In the nine months ended January 30, 2021, we recognized $3.3 million of restructuring costs related to actions taken to reduce overall costs and improve operational profitability, compared to $1.0 million of restructuring costs recognized in the nine months ended February 1, 2020.

Amortization of Intangibles. Amortization of intangibles increased $0.2 million, or 1.4%, to $14.5 million in the nine months ended January 30, 2021, compared to $14.3 million in the nine months ended February 1, 2020.

Interest Expense, Net. Interest expense, net was $4.3 million in the nine months ended January 30, 2021, compared to $8.0 million in the nine months ended February 1, 2020. The decrease was due to a lower effective interest rate on outstanding borrowings, partially offset by higher average borrowings. Average borrowings were higher due to the precautionary $100.0 million draw-dawn in March 2020, which was fully repaid in the three months ended January 30, 2021.

Other Income, Net. Other income, net was $8.4 million in the nine months ended January 30, 2021, compared to $5.8 million in the nine months ended February 1, 2020. In the nine months ended January 30, 2021, we received $8.9 million of government assistance at certain of our international locations with respect to the COVID-19 pandemic. The nine months ended February 1, 2020 includes $5.6 million for an international government grant for maintaining certain employment levels during those periods. In the nine months ended February 1, 2020, we sold assets related to a previously closed business and recognized a gain on sale of $0.5 million.

Income Tax Expense. Income tax expense was $7.1 million (7.2% effective tax rate) in the nine months ended January 30, 2021, compared to $15.3 million (14.1% effective tax rate) in the nine months ended February 1, 2020. The lower effective tax rate in the nine months ended January 30, 2021 was primarily due to discrete tax benefits recorded of $7.6 million. These discrete tax benefits included tax credits earned and research deductions claimed in foreign jurisdictions. Excluding the discrete tax benefits, the effective tax rate would have been 15.0%. In the nine months ended February 1, 2020, income tax expense included discrete tax expenses of $1.5 million. Excluding the discrete tax expense, the effective tax rate would have been 15.5%.

Net Income. Net income decreased $2.1 million, or 2.3%, to $91.2 million in the nine months ended January 30, 2021, compared to $93.3 million in the nine months ended February 1, 2020. Net income decreased as a result of the reasons described above, partially offset by favorable foreign currency translation of $3.3 million.

30

Table of Contents

Operating Segments

Automotive Segment Results

Below is a table summarizing results for the nine months ended:

|  | January 30, 2021 |  |  | February 1, 2020 |  |  |  |  |  |  |  |  |
(Dollars in Millions) |  | (39 Weeks) |  |  | (40 Weeks) |  |  | Net Change ($) |  |  | Net Change (%) |
Net Sales |  | $ | 551.3 |  |  | $ | 576.6 |  |  | $ | (25.3 | ) |  |  | (4.4 | )%
Gross Profit |  | $ | 123.2 |  |  | $ | 146.6 |  |  | $ | (23.4 | ) |  |  | (16.0 | )%
Income from Operations |  | $ | 83.7 |  |  | $ | 101.2 |  |  | $ | (17.5 | ) |  |  | (17.3 | )%
Percent of sales: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net Sales |  |  | 100.0 | % |  |  | 100.0 | % |  |  |  |  |  |  |  |
Gross Profit |  |  | 22.3 | % |  |  | 25.4 | % |  |  |  |  |  |  |  |
Income from Operations |  |  | 15.2 | % |  |  | 17.6 | % |  |  |  |  |  |  |  |

Net Sales. Automotive segment net sales decreased $25.3 million, or 4.4%, to $551.3 million in the nine months ended January 30, 2021, compared to $576.6 million in the nine months ended February 1, 2020. The impact of foreign currency translation increased net sales by $12.4 million. Excluding foreign currency translation, net sales decreased $37.7 million. Net sales were negatively impacted in our first quarter of fiscal 2021 from the COVID-19 pandemic, which was partially offset by higher sales in our second quarter of fiscal 2021 as a result of pent-up demand. Net sales in North America decreased $56.8 million, or 15.8%, to $301.8 million in the nine months ended January 30, 2021, compared to $358.6 million in the nine months ended February 1, 2020. The decrease was due to lower electric vehicle product sales which shifted from North America to Asia and lower lighting product sales volumes. Net sales in the nine months ended February 1, 2020 were negatively impacted by $28.7 million due to the UAW labor strike at GM. Net sales in Europe decreased $11.8 million, or 7.4%, to $147.1 million in the nine months ended January 30, 2021, compared to $158.9 million in the nine months ended February 1, 2020. The stronger euro, relative to the U.S. dollar, increased net sales by $8.4 million. Excluding foreign currency translation, net sales in Europe decreased $20.2 million due to lower sales volumes, primarily in the first quarter of fiscal 2021, as a result of the COVID-19 pandemic. Net sales in Asia increased $43.3 million, or 73.3%, to $102.4 million in the nine months ended January 30, 2021, compared to $59.1 million in the nine months ended February 1, 2020. The stronger Chinese renminbi, relative to the U.S. dollar, increased net sales in Asia by $4.0 million. Excluding foreign currency translation, Asia net sales increased $39.3 million primarily due to higher electric vehicle product sales volumes which were transferred from North America, higher leadframe sales volumes and higher touchscreen sales volumes to an Asian automotive OEM, which launched in the second half of fiscal 2020.

Gross Profit. Automotive segment gross profit decreased $23.4 million, or 16.0%, to $123.2 million in the nine months ended January 30, 2021, compared to $146.6 million in the nine months ended February 1, 2020. Automotive segment gross profit margins decreased to 22.3% in the nine months ended January 30, 2021, compared to 25.4% in the nine months ended February 1, 2020. The decrease in gross profit margins was primarily due to the impact of the COVID-19 pandemic on sales volumes and restructuring actions taken in fiscal 2021. In the nine months ended January 30, 2021, we recognized $5.0 million of restructuring costs related to actions taken to reduce overall costs and improve operational profitability, compared to $0.6 million of restructuring costs recognized in the nine months ended February 1, 2020.

Income from Operations. Automotive segment income from operations decreased $17.5 million, or 17.3%, to $83.7 million in the nine months ended January 30, 2021, compared to $101.2 million in the nine months ended February 1, 2020. The impact of foreign currency translation increased automotive segment income from operations by $2.3 million. Excluding foreign currency translation, automotive segment income from operations decreased $19.8 million. The decrease was primarily due to lower gross profit, partially offset by lower selling and administrative expenses. Selling and administrative expenses decreased due to lower compensation expense, partially offset by restructuring costs. Total restructuring costs related to actions taken to reduce overall costs and improve operational profitability were $6.4 million in the nine months ended January 30, 2021, compared to $0.7 million of restructuring costs in the nine months ended February 1, 2020.

31

Table of Contents

Industrial Segment Results

Below is a table summarizing results for the nine months ended:

|  | January 30, 2021 |  |  | February 1, 2020 |  |  |  |  |  |  |  |  |
(Dollars in Millions) |  | (39 Weeks) |  |  | (40 Weeks) |  |  | Net Change ($) |  |  | Net Change (%) |
Net Sales |  | $ | 186.4 |  |  | $ | 195.8 |  |  | $ | (9.4 | ) |  |  | (4.8 | )%
Gross Profit |  | $ | 65.5 |  |  | $ | 72.9 |  |  | $ | (7.4 | ) |  |  | (10.2 | )%
Income from Operations |  | $ | 40.0 |  |  | $ | 44.8 |  |  | $ | (4.8 | ) |  |  | (10.7 | )%
Percent of sales: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net Sales |  |  | 100.0 | % |  |  | 100.0 | % |  |  |  |  |  |  |  |
Gross Profit |  |  | 35.1 | % |  |  | 37.2 | % |  |  |  |  |  |  |  |
Income from Operations |  |  | 21.5 | % |  |  | 22.9 | % |  |  |  |  |  |  |  |

Net Sales. Industrial segment net sales decreased $9.4 million, or 4.8%, to $186.4 million in the nine months ended January 30, 2021, compared to $195.8 million in the nine months ended February 1, 2020. The impact of foreign currency translation increased net sales by $2.8 million. Excluding foreign currency translation, net sales decreased $12.2 million. The decrease was primarily due to lower sales from commercial vehicle lighting solutions and radio remote control devices which were adversely impacted from the COVID-19 pandemic. This was partially offset by higher sales volumes of electric vehicle busbar products.

Gross Profit. Industrial segment gross profit decreased $7.4 million, or 10.2%, to $65.5 million in the nine months ended January 30, 2021, compared to $72.9 million in the nine months ended February 1, 2020. Gross profit margins decreased to 35.1% in the nine months ended January 30, 2021, compared to 37.2% in the nine months ended February 1, 2020. The decrease in gross profit margins was primarily due to the impact of the COVID-19 pandemic on commercial vehicle lighting solutions and radio remote control product sales. This was partially offset by higher gross profit margins from busbar products.

Income from Operations. Industrial segment income from operations decreased $4.8 million, or 10.7%, to $40.0 million in the nine months ended January 30, 2021, compared to $44.8 million in the nine months ended February 1, 2020. The decrease was primarily due to lower gross profit, higher legal fees and restructuring costs, partially offset by higher income from operations from busbar products. In the nine months ended January 30, 2021, we recognized $0.9 million of restructuring costs related to actions taken to reduce overall costs and improve operational profitability, compared to $0.4 million of restructuring costs recognized in the nine months ended February 1, 2020.

Interface Segment Results

Below is a table summarizing results for the nine months ended:

|  | January 30, 2021 |  |  | February 1, 2020 |  |  |  |  |  |  |  |  |
(Dollars in Millions) |  | (39 Weeks) |  |  | (40 Weeks) |  |  | Net Change ($) |  |  | Net Change (%) |
Net Sales |  | $ | 47.4 |  |  | $ | 39.7 |  |  | $ | 7.7 |  |  |  | 19.4 | %
Gross Profit |  | $ | 10.1 |  |  | $ | 4.5 |  |  | $ | 5.6 |  |  |  | 124.4 | %
Income from Operations |  | $ | 7.4 |  |  | $ | 0.7 |  |  | $ | 6.7 |  |  | N/M* |
Percent of sales: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net Sales |  |  | 100.0 | % |  |  | 100.0 | % |  |  |  |  |  |  |  |
Gross Profit |  |  | 21.3 | % |  |  | 11.3 | % |  |  |  |  |  |  |  |
Income from Operations |  |  | 15.6 | % |  |  | 1.8 | % |  |  |  |  |  |  |  |
*N/M equals non-meaningful |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

Net Sales. Interface segment net sales increased $7.7 million, or 19.4%, to $47.4 million in the nine months ended January 30, 2021, compared to $39.7 million in the nine months ended February 1, 2020. The increase was primarily due to higher sales volumes of appliance products, partially offset by lower sales volumes of legacy data solutions products.

32

Table of Contents

Gross Profit. Interface segment gross profit increased $5.6 million, or 124.4%, to $10.1 million in the nine months ended January 30, 2021, compared to $4.5 million in the nine months ended February 1, 2020. Gross profit margins increased to 21.3% in the nine months ended January 30, 2021, from 11.3% in the nine months ended February 1, 2020. The increase was primarily due to higher sales volumes of appliance products and lower operati onal costs.

Income from Operations. Interface segment income from operations increased $6.7 million to $7.4 million in the nine months ended January 30, 2021, compared to $0.7 million in the nine months ended February 1, 2020. The increase was primarily due to higher gross profit and lower selling and administrative expenses, partially offset by restructuring costs recognized in the first quarter of fiscal 2021. Selling and administrative expenses in the nine months ended January 30, 2021 benefitted from restructuring actions taken in the first quarter of fiscal 2021. In the nine months ended January 30, 2021, we recognized $0.7 million of restructuring costs related to actions taken to reduce overall costs and improve operational profitability.

Medical Segment Results

Below is a table summarizing results for the nine months ended:

|  | January 30, 2021 |  |  | February 1, 2020 |  |  |  |  |  |  |  |  |
(Dollars in Millions) |  | (39 Weeks) |  |  | (40 Weeks) |  |  | Net Change ($) |  |  | Net Change (%) |
Net Sales |  | $ | 1.9 |  |  | $ | 1.2 |  |  | $ | 0.7 |  |  |  | 58.3 | %
Gross Profit |  | $ | (1.0 | ) |  | $ | (1.3 | ) |  | $ | 0.3 |  |  |  | (23.1 | )%
Loss from Operations |  | $ | (4.1 | ) |  | $ | (4.9 | ) |  | $ | 0.8 |  |  |  | (16.3 | )%

Net Sales. The Medical segment had net sales of $1.9 million in the nine months ended January 30, 2021, compared to $1.2 million in the nine months ended February 1, 2020. Net sales increased due to higher product demand.

Gross Profit. Medical segment gross profit was a loss of $1.0 million in the nine months ended January 30, 2021, compared to a loss of $1.3 million in the nine months ended February 1, 2020. The improvement was due to higher net sales.

Loss from Operations. Medical segment loss from operations was $4.1 million in the nine months ended January 30, 2021, compared to $4.9 million in the nine months ended February 1, 2020. The improvement was due to higher net sales and lower selling and administrative costs.

Financial Condition, Liquidity and Capital Resources

Credit Agreement

Our primary sources of liquidity are cash flows from operations, existing cash balances and borrowings under our senior unsecured credit agreement. We believe our liquidity position will be sufficient to fund our existing operations and current commitments for at least the next twelve months. However, if economic conditions remain impacted for longer than we expect due to the COVID-19 pandemic, our liquidity position could be severely impacted.

Our senior unsecured credit agreement provides for a $200.0 million revolving credit facility and a $250.0 million term loan. In March 2020, as a precautionary measure in response to the COVID-19 pandemic, we drew down $100.0 million under our revolving credit facility, which we repaid in the third quarter of fiscal 2021. As of January 30, 2021, $9.7 million in principal was outstanding under the revolving credit facility and we have $190.1 million of availability under the revolving credit facility. As of January 30, 2021, $221.9 million in principal was outstanding under the term loan. The term loan matures in September 2023 and requires quarterly principal payments of $3.1 million over the five-year term, with the remaining balance due upon maturity. We were in compliance with all covenants under the senior unsecured credit agreement as of January 30, 2021. For further information, see Note 7, "Debt," to the condensed consolidated financial statements included in this Quarterly Report.

Borrowings under our senior unsecured credit agreement bear interest at rates equal to the London Interbank Offered Rate (“LIBOR”) plus an applicable margin. LIBOR is expected to be phased out by the end of 2021, which is before the maturity of our senior unsecured credit agreement. At this time, there is no definitive information regarding the future utilization of LIBOR or of any particular replacement rate; however, we continue to monitor the efforts of various parties, including government agencies, seeking to

33

Table of Contents

identify an alternative rate to replace LIBOR. The consequences of the discontinuance of LIBOR cannot be entirely predicted but could result in an increase in our interest expense.

Our senior unsecured credit agreement provides an option to increase the size of our revolving credit facility and term loan by an additional $200.0 million, subject to customary conditions and approval of the lenders providing the new commitments. There can be no assurance that lenders will approve additional commitments under current circumstances. As a result of the impacts of the COVID-19 pandemic, we may be required to raise additional capital and our access to, and cost of, financing will depend on, among other things, global economic conditions, conditions in the global financing markets, the availability of sufficient amounts of financing, and our future prospects.

At January 30, 2021, we had $218.7 million of cash and cash equivalents, of which $132.6 million was held in subsidiaries outside the U.S. Cash held by these subsidiaries is used to fund operational activities and can be repatriated, primarily through the payment of dividends and the repayment of intercompany loans, without creating material additional income tax expense.

Cash Flows

Cash flow is summarized below:

|  | Nine Months Ended |
|  | January 30, 2021 |  |  | February 1, 2020 |
(Dollars in Millions) |  | (39 Weeks) |  |  | (40 Weeks) |
Operating activities: |  |  |  |  |  |  |  |
Net Income |  | $ | 91.2 |  |  | $ | 93.3 |
Non-cash Items |  |  | 37.3 |  |  |  | 41.4 |
Changes in Operating Assets and Liabilities |  |  | 15.3 |  |  |  | (52.1 | )
Net Cash Provided by Operating Activities |  |  | 143.8 |  |  |  | 82.6 |
Net Cash Used in Investing Activities |  |  | (20.0 | ) |  |  | (34.4 | )
Net Cash Used in Financing Activities |  |  | (127.8 | ) |  |  | (49.7 | )
Effect of Exchange Rate Changes on Cash and Cash Equivalents |  |  | 5.4 |  |  |  | (1.8 | )
Net Increase (Decrease) in Cash and Cash Equivalents |  |  | 1.4 |  |  |  | (3.3 | )
Cash and Cash Equivalents at Beginning of the Year |  |  | 217.3 |  |  |  | 83.2 |
Cash and Cash Equivalents at End of the Period |  | $ | 218.7 |  |  | $ | 79.9 |

Operating Activities

Net cash provided by operating activities increased $61.2 million to $143.8 million in the nine months ended January 30, 2021, compared to $82.6 million in the nine months ended February 1, 2020. The increase was due to higher cash inflows related to changes in operating assets and liabilities, partially offset by lower net income adjusted for non-cash items. The $15.3 million of cash inflows for operating assets and liabilities in the nine months ended January 30, 2021 was primarily due to higher accounts payable, lower prepaid expenses and other assets and lower inventory, partially offset by higher accounts receivable.

Investing Activities

Net cash used in investing activities was $20.0 million in the nine months ended January 30, 2021, compared to $34.4 million in the nine months ended February 1, 2020. The activity in both the nine months ended January 30, 2021 and February 1, 2020 relates primarily to purchases of property, plant and equipment.

Financing Activities

Net cash used in financing activities was $127.8 million in the nine months ended January 30, 2021, compared to $49.7 million in the nine months ended February 1, 2020. We paid dividends of $13.2 million in the nine months ended January 30, 2021, compared to $12.2 million in the nine months ended February 1, 2020. In the nine months ended January 30, 2021, we paid $3.9 million in taxes related to the net share settlement of equity awards compared to $0.4 million in the nine months ended February 1, 2020. In the nine months ended January 30, 2021, we had net repayments on our borrowings of $110.4 million, which included the repayment of the $100.0 million pre-cautionary draw-down on our revolving credit facility in March 2020. In the nine months ended February 1, 2020, net repayments on our borrowings were $36.6 million.

34

Table of Contents

Recent Accounting Pronouncements

See Note 1, "Description of Business and Summary of Significant Accounting Policies" to the condensed consolidated financial statements included in Item 1.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements, as defined under SEC rules.

Legal Matters

For several years, Hetronic Germany-GmbH and Hydronic-Steuersysteme-GmbH (the “Fuchs companies”) served as our distributors for Germany, Austria and other central and eastern European countries pursuant to their respective intellectual property licenses and distribution and assembly agreements. We became aware that the Fuchs companies and their managing director, Albert Fuchs, had materially violated those agreements. As a result, we terminated all of our agreements with the Fuchs companies. On June 20, 2014, we filed a lawsuit against the Fuchs companies in the Federal District Court for the Western District of Oklahoma alleging material breaches of the distribution and assembly agreements and seeking damages, as well as various forms of injunctive relief. The defendants filed counterclaims alleging breach of contract, interference with business relations and business slander. On April 2, 2015, we amended our complaint against the Fuchs companies to add additional unfair competition and Lanham Act claims and to add additional affiliated parties. A trial with respect to the matter began in February 2020. During the trial, the defendants dismissed their one remaining counterclaim with prejudice. On March 2, 2020, the jury returned a verdict in our favor. The verdict included approximately $102 million in compensatory damages and $11 million in punitive damages. On April 22, 2020, the Court entered a permanent injunction barring defendants from selling infringing products and ordering them to return Hetronic’s confidential information. Defendants appealed entry of the permanent injunction. On May 29, 2020, the Court held defendants in contempt for violating the permanent injunction and entered the final judgment. Defendants appealed entry of the final monetary judgment as well. The appeal of the permanent injunction and the appeal of the final judgment have been consolidated into a single appeal. That appeal is fully briefed and has been set for argument on March 8, 2021. The Court will issue a decision sometime thereafter. We are working with counsel to collect on the judgment though there are challenges in Europe in doing so while the appeal is pending. Like any judgment, particularly any judgment involving defendants outside of the United States, there is no guarantee that we will be able to collect the judgment.

In the nine months ended January 30, 2021 and February 1, 2020, we incurred Hetronic-related legal fees of $4.8 million and $3.3 million, respectively. These amounts are included in the selling and administrative expenses in the Industrial segment.

35

Table of Contents

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are exposed to market risks from foreign currency exchange, interest rates, and commodity prices, which could affect our operating results, financial position and cash flows. We manage a portion of these risks through use of derivative financial instruments in accordance with our policies. We do not enter into derivative financial instruments for speculative or trading purposes.

Foreign Currency Risk

We are exposed to foreign currency risk on sales, costs and assets and liabilities denominated in currencies other than the U.S. dollar. We seek to manage our foreign exchange risk largely through operational means, including matching revenue with same-currency costs and assets with same-currency liabilities. We currently transact business in eight primary currencies worldwide, of which the most significant were the U.S. dollar, the euro, the Mexican peso, and the Chinese renminbi.

A portion of our balance sheet is exposed to foreign currency exchange rate fluctuations, which may result in non-operating foreign currency exchange gains or losses upon remeasurement. In the nine months ended January 30, 2021, we reported foreign currency exchange losses of approximately $0.7 million, which were primarily attributed to the remeasurement of net monetary assets and liabilities denominated in currencies other than the functional currencies of our subsidiaries. In January 2021, we began to use foreign currency forward contracts to provide an economic hedge against balance sheet exposure to certain monetary assets and liabilities denominated in currencies other than the functional currency of the subsidiary. The forward contracts have a maturity of less than three months and are not designated as hedging instruments. At January 30, 2021, the notional value of these outstanding contracts was $21.9 million, and the net unrealized loss was $0.2 million. The impact of a change in the foreign currency exchange rates on our foreign currency forward contracts will generally be offset against the gain or loss from the re-measurement of the underlying balance sheet exposure.

The translation of the assets and liabilities of our international subsidiaries is made using the foreign currency exchange rates as of the end of the reporting period. Translation adjustments are not included in determining net income but are included in accumulated other comprehensive income (loss) within shareholders’ equity on the condensed consolidated balance sheets until a sale or substantially complete liquidation of the net investment in the international subsidiary takes place. As of January 30, 2021, the cumulative net currency translation adjustments increased shareholders’ equity by $14.0 million. We have outstanding a euro denominated cross-currency swap which is treated as a net investment hedge to reduce our exposure to translational exchange risk. As of January 30, 2021, we recorded a deferred loss, net of tax, of $5.8 million related to the cross-currency swap.

Interest Rate Risk

We are exposed to market risk from changes in interest rates. The interest rate risk for our senior unsecured credit agreement, under which we had $231.6 million of net borrowings as of January 30, 2021, is variable and is based on LIBOR. We estimate that a 1% increase in interest rates under our senior unsecured credit agreement would result in increased annual interest expense of $2.3 million.

Commodity Price Risk

We are exposed to commodity price risk primarily on our raw material purchases. These raw materials are not rare or unique to our industry. The cost of copper, resins, and other commodities, such as fuel and energy, has fluctuated in recent years due to changes in global supply and demand. The cost of copper has increased significantly in fiscal 2021. Our gross margins could be affected if these types of costs continue to fluctuate. We actively manage these raw material costs through global sourcing initiatives and price increases on our products. However, in the short-term, rapid increases in raw material costs can be very difficult to offset with price increases because of contractual agreements with our customers.

Item 4. Controls and Procedures

As of the end of the period covered by this quarterly report on Form 10-Q, we performed an evaluation under the supervision and with the participation of the Company’s management, including our Chief Executive Officer and our Chief Financial Officer, of our “disclosure controls and procedures” (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934). The Company’s disclosure controls and procedures are designed to ensure that the information required to be disclosed by the Company in the reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s applicable rules and forms. As a result of this evaluation, our

36

Table of Contents

Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of the period covered by this report, the Company’s disclosure controls and procedures were effective.

There have been no changes in our internal control over financial reporting during the quarter ended January 30, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

37

Table of Contents

PART II. OTHER INFORMATION

Item 1A. Risk Factors

The Company's business, financial condition, results of operations and cash flows are subject to various ‎risks which could cause actual results to vary from recent results or from anticipated future results. There have ‎been no material changes to the risk factors disclosed in Part I - Item 1A, Risk Factors of our Form 10-K for the ‎fiscal year ended May 2, 2020 except as set forth below.‎

The effects of the COVID-19 pandemic have had and could continue to have a material adverse impact on our business, results of operations and financial condition.

The COVID-19 pandemic continues to impact worldwide economic activity. As a result of the COVID-19 pandemic, we, our employees, our suppliers, our customers and others may be restricted or prevented from conducting business activities for indefinite or intermittent periods of time, including as a result of employee health and safety concerns, shutdowns, shelter in place orders, travel restrictions and other actions and restrictions that may be requested or mandated by governmental authorities.

While we have implemented measures to mitigate the impact of the COVID-19 pandemic, there can be no assurance that these measures will be successful. As a result, we expect our full-year fiscal 2021 results of operations to be adversely affected by the COVID-19 pandemic, and our fiscal 2022 result of operations may also be adversely affected. The extent of the impact on our business will depend on a number of evolving factors, including the duration and spread of the pandemic, as well as the possibility of the pandemic re-occurring, actions taken by governmental authorities to restrict certain business operations and social activity and impose travel restrictions, the impact of the pandemic on economic activity and whether recessionary conditions will persist, consumer demand, the ability of our supply chain to deliver in a timely and cost-effective manner, the ability of our employees and manufacturing facilities to operate efficiently and effectively, the continued viability and financial stability of our customers and suppliers and future access to capital, all of which remain uncertain. As a result, the magnitude and duration of the impact on our business, results of operations and financial condition cannot be determined at this time.

The automotive and commercial vehicle industries are our primary markets. The COVID-19 pandemic has significantly disrupted, and may continue to significantly disrupt, the global automotive and commercial vehicle industries and customer sales, production volumes and purchases of vehicles by end consumers. In addition, the spread of COVID-19 has created a significant disruption in the manufacturing, delivery and overall supply chain of automobile and commercial vehicle manufacturers and suppliers. Further, the COVID-19 pandemic resulted in a temporary shutdown of substantially all of the major OEMs in our markets at various times in calendar 2020, which impacted our sales volumes. Although automotive and commercial vehicle production has resumed, customer sales and production volumes may significantly decrease or may be very volatile due to global economic impacts and uncertainties. At the end of our third quarter of fiscal 2021, many automotive companies announced a slowdown in their production schedules due to the worldwide semiconductor shortage.

In addition to the risks specifically described above, the COVID-19 pandemic has exacerbated and precipitated the other risks described in our Annual Report on Form 10-K for the year ended May 2, 2020, and may continue to do so, in ways that we are not currently able to predict, any of which could significantly adversely affect our business, results of operations, financial condition, cash flows, liquidity or stock price.

Supply chain disruptions, including the current semiconductor and resin shortages, could be materially adverse to our operations, profitability and results of operations.

The significant vehicle production slowdown in our first quarter of fiscal 2021 as a result of COVID-19 was followed by increased consumer demand and accelerated vehicle production schedules in our second and third quarters of fiscal 2021. This surge in demand led to a worldwide semiconductor supply shortage in early calendar 2021, as semiconductor suppliers have been unable to rapidly reallocate production lines to serve the automotive industry. In addition, t he recent storms in the Gulf Coast caused outages, closures and damages at several petrochemical facilities that are expected to disrupt the supply chains for several products, including resins. If such shortages of semiconductors, resins or other critical components continue, or worsen, it could impact our ability to meet our production schedules for some of our key products or to ship such products to our customers in a timely fashion.

38

Table of Contents

Additionally, our customers’ production schedu les could be impacted by these shortages, which could result in reduced sales of our products. Furthermore, unfavorable economic or industry conditions could result in financial distress within our supply base, thereby increasing the risk of supply disrup tion.

Item 6. Exhibits

Exhibit Number |  | Description
10.1 |  | Methode Electronics, Inc. Deferred Compensation Plan, as amended and restated as of November 12, 2020 (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed on November 13, 2020)
31.1 |  | Rule 13a-14(a)/15d-14(a) Certification of Principal Executive Officer
31.2 |  | Rule 13a-14(a)/15d-14(a) Certification of Principal Financial Officer
32 |  | Certification of Periodic Financial Report Pursuant to 18 U.S.C. Section 1350
101.1 |  | Inline XBRL Instance
101.2 |  | Inline XBRL Taxonomy Extension Schema Document
101.3 |  | Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.4 |  | Inline XBRL Taxonomy Extension Label Linkbase Document
101.5 |  | Inline XBRL Taxonomy Extension Presentation Linkbase Document
101.6 |  | Inline XBRL Taxonomy Extension Definition Linkbase Document
104 |  | The cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended January 30, 2021, formatted as Inline XBRL and contained in Exhibit 101

39

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

|  |  |  | METHODE ELECTRONICS, INC.
|  |  |  | By: |  | /s/ Ronald L.G. Tsoumas
|  |  |  |  |  | Ronald L.G. Tsoumas
|  |  |  |  |  | Chief Financial Officer
|  |  |  |  |  | (Principal Financial Officer)
Dated: |  | March 4, 2021 |  |  |  |

40